Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Fractures

  Free Subscription


Articles published in Osteoporos Int

Retrieve available abstracts of 613 articles:
HTML format



Single Articles


    February 2025
  1. MAKKAR B, Obremskey W, Avidano R, Ott S, et al
    The definition of atypical femoral fractures should include periprosthetic femoral fractures (PAFFs).
    Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-025-07401.
    PubMed     Abstract available


  2. NISSINEN T, Sund R, Suoranta S, Kroger H, et al
    Identifying proximal humerus fractures: an algorithmic approach using registers and radiological visit data.
    Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-025-07414.
    PubMed     Abstract available


  3. NAKAJIMA K, Horii C, Kodama H, Shirokoshi T, et al
    Association between vertebral fractures and brain volume: insights from a community cohort study.
    Osteoporos Int. 2025 Feb 5. doi: 10.1007/s00198-025-07403.
    PubMed     Abstract available


    January 2025
  4. KAWAMURA K, Murata S, Kitano Y, Mera Y, et al
    Metaphyseal comminution in distal radius fractures: a predictor of secondary fragility fractures and the role of osteoporosis treatment.
    Osteoporos Int. 2025 Jan 28. doi: 10.1007/s00198-025-07404.
    PubMed     Abstract available


  5. DURBIN JW, Zhao AY, Cui E, Agarwal AR, et al
    Trends in screening and treatment of osteoporosis after periprosthetic fractures from 2010 to 2020.
    Osteoporos Int. 2025 Jan 15. doi: 10.1007/s00198-025-07385.
    PubMed     Abstract available


  6. ANDREASEN C, Dahl C, Frihagen F, Borgen TT, et al
    Fracture liaison service (FLS) is associated with lower subsequent fragility fracture risk and mortality: NoFRACT (the Norwegian capture the fracture initiative).
    Osteoporos Int. 2025 Jan 14. doi: 10.1007/s00198-024-07376.
    PubMed     Abstract available


  7. IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
    Author response to: Comment from Dongdong Cao, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
    Osteoporos Int. 2025 Jan 14. doi: 10.1007/s00198-025-07383.
    PubMed    


  8. CAO D, Cao Z, Liu A
    Comment on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
    Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07374.
    PubMed    


  9. HOLLTRO HT, Nilsen TIL, Schei B, Tronstad I, et al
    Is there an association between birth characteristics and fractures in young adults? The HUNT Study, Norway.
    Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07361.
    PubMed     Abstract available


  10. AKKAN H, Seyyar GK
    Improving readability in AI-generated medical information on fragility fractures: the role of prompt wording on ChatGPT's responses.
    Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07358.
    PubMed     Abstract available


  11. HIRSCH JA, Gilligan C, Chandra RV, Brook A, et al
    Real-world rates and risk factors for subsequent treatment with vertebroplasty or balloon kyphoplasty after initial vertebral augmentation: a retrospective cohort study.
    Osteoporos Int. 2025;36:129-140.
    PubMed     Abstract available


    December 2024
  12. LIN YC, Chiang PH, Huang JY, Wu WS, et al
    Osteoporotic fracture risks of thiazides and dihydropyridines in angiotensin modulator users.
    Osteoporos Int. 2024 Dec 27. doi: 10.1007/s00198-024-07356.
    PubMed     Abstract available


  13. NAGENDRA L, Chandran M, Reginster JY, Bhadada SK, et al
    Cost-effectiveness of FRAX(R)-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysis.
    Osteoporos Int. 2024 Dec 27. doi: 10.1007/s00198-024-07328.
    PubMed     Abstract available


  14. BLAKE RJ, Melemai VK, Fitzpatrick BM, Hubbard DF, et al
    Bilateral femoral neck fractures in pregnancy suggestive of transient osteoporosis of the hip in a patient with hyperparathyroidism: a case report.
    Osteoporos Int. 2024 Dec 24. doi: 10.1007/s00198-024-07346.
    PubMed     Abstract available


  15. YOEL U, Alkobi Weiss H, Goldbart A, Silverman Siris E, et al
    The impact of a fracture liaison service with in-hospital anti-osteoporosis treatment on subsequent hip fracture and mortality rates-a single-center retrospective study.
    Osteoporos Int. 2024 Dec 18. doi: 10.1007/s00198-024-07325.
    PubMed     Abstract available


  16. CAO D, Chen J, Yu W
    Comment on: Among people on osteoporosis medication, loss of appendicular or total body lean mass is an independent risk factor for hip and major osteoporotic fractures.
    Osteoporos Int. 2024 Dec 17. doi: 10.1007/s00198-024-07306.
    PubMed    


  17. IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
    Author Response to: Comment from Zahra Ali Haque, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan
    Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07332.
    PubMed    


  18. VAN OOSTWAARD M, van den Bergh JP, Wyers CE
    Author response to 01530, Proactive strategies for fracture risk in androgen deprivation therapy: a call for multidisciplinary collaboration.
    Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07322.
    PubMed    


  19. RAZA MH, Bhutta ME, Siddique MH
    Proactive strategies for fracture risk in androgen deprivation therapy: a call for multidisciplinary collaboration.
    Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07330.
    PubMed    


  20. KIM CH, Kim K, Kim JW
    The effect of denosumab on minimum 3-years BMD changes in patients with osteoporotic hip fractures: a propensity score matching analysis.
    Osteoporos Int. 2024 Dec 13. doi: 10.1007/s00198-024-07314.
    PubMed     Abstract available


  21. GONDO G, Shin JH, Kunisawa S, Imanaka Y, et al
    Impact of the guidance on fracture Liaison Services and the introduction of a new fee for secondary fracture prevention in Japan: Implementation of secondary fracture prevention during hospitalization for fragility fractures.
    Osteoporos Int. 2024 Dec 13. doi: 10.1007/s00198-024-07269.
    PubMed     Abstract available


  22. NARLA RR, Adler RA
    Rationale for osteoporosis screening in men.
    Osteoporos Int. 2024 Dec 13. doi: 10.1007/s00198-024-07337.
    PubMed     Abstract available


  23. IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
    Author Response to: Comment from Cheng Gu and Yu Cui on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
    Osteoporos Int. 2024 Dec 10. doi: 10.1007/s00198-024-07333.
    PubMed    


  24. GU C, Cui Y
    Comment on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
    Osteoporos Int. 2024 Dec 10. doi: 10.1007/s00198-024-07327.
    PubMed    


  25. XU P, Luo J
    Comment on "Higher prevalence of thyroid?specific autoantibodies (TPOAb and TgAb) is related to a higher prevalence of fractures in females: results from NHANES 2007-2010".
    Osteoporos Int. 2024 Dec 9. doi: 10.1007/s00198-024-07334.
    PubMed    


  26. SALMORAL A, Peris P, Lopez Medina C, Florez H, et al
    Bisphosphonate drug holidays in osteoporosis according to fracture risk profile.
    Osteoporos Int. 2024 Dec 3. doi: 10.1007/s00198-024-07309.
    PubMed     Abstract available


  27. MARTIN DP 2ND, Lake S, Behun M, Krueger D, et al
    Intraoperative physician assessment during total hip arthroplasty correlates with DXA parameters.
    Osteoporos Int. 2024;35:2145-2151.
    PubMed     Abstract available


  28. TSAI JN, Jordan M, Lee H, Leder BZ, et al
    One versus 2 years of alendronate following denosumab: the CARD extension.
    Osteoporos Int. 2024;35:2225-2230.
    PubMed     Abstract available


    November 2024
  29. AZAD TD, Wu RJ, Anderson KE, Darden M, et al
    Osteoporosis testing and treatment remain low in both Traditional Medicare and Medicare Advantage.
    Osteoporos Int. 2024 Nov 21. doi: 10.1007/s00198-024-07318.
    PubMed     Abstract available


  30. ONTAN MS, Cam Mahser A, Dost FS, Isik AT, et al
    Osteoporosis in older patients with idiopathic normal pressure hydrocephalus.
    Osteoporos Int. 2024 Nov 18. doi: 10.1007/s00198-024-07317.
    PubMed     Abstract available


  31. TAYLOR-WILLIAMS O, Keen H, Preen DB, Nossent J, et al
    First fracture in rheumatoid arthritis: analysis by fracture site, gender, age, and comorbidities.
    Osteoporos Int. 2024 Nov 12. doi: 10.1007/s00198-024-07311.
    PubMed     Abstract available


  32. DE BRUIN IJA, Wyers CE, Vranken L, Schousboe JT, et al
    Systematic evaluation of abdominal aortic calcification in patients with a recent clinical fracture visiting the Fracture Liaison Service.
    Osteoporos Int. 2024 Nov 12. doi: 10.1007/s00198-024-07288.
    PubMed     Abstract available


  33. SOOPRAMANIEN J, Wakefield A, Marshall L, Nightingale J, et al
    Assessing the impact of the 5 Nations Consensus Paper on IV Zolendronate administration post-hip fracture in older patients: experience from a UK teaching hospital.
    Osteoporos Int. 2024 Nov 4. doi: 10.1007/s00198-024-07303.
    PubMed    


    October 2024
  34. CAO D, Gu N, Liu A
    Comment on: Low-dose glucocorticoid increase the risk of fracture in postmenopausal women with low bone mass: a retrospective cohort study.
    Osteoporos Int. 2024 Oct 23. doi: 10.1007/s00198-024-07248.
    PubMed    


  35. ZHOU K, Li R, Wang J
    Letter to the editor concerning "Sex differences in hemoglobin levels and five-year refracture risk in patients with osteoporotic fractures: a retrospective cohort analysis".
    Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07287.
    PubMed    


  36. IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
    Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
    Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07284.
    PubMed     Abstract available


  37. SHARMA M, Beaudart C, Clark P, Fujiwara S, et al
    Clinical and demographic factors determining patient fracture risk decision point (FRDP): The improving risk communication in osteoporosis (RICO) project.
    Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07264.
    PubMed     Abstract available


  38. TORO LA, Gonzalez FI, Botero S, Garcia HD, et al
    Handgrip strength as a predictor of 1?year mortality after hip fracture surgery in the Colombian Andes Mountains.
    Osteoporos Int. 2024 Oct 17. doi: 10.1007/s00198-024-07258.
    PubMed     Abstract available


  39. BARCELOS A, Lopes DG, Mazeda C, Canhao H, et al
    Regular physical activity improves physical function and health-related quality of life among middle-aged and older women who suffered a fragility fracture-a population-based cohort.
    Osteoporos Int. 2024 Oct 11. doi: 10.1007/s00198-024-07265.
    PubMed     Abstract available


  40. SAHOTA A, Vass C, Marshall L, Sahota O, et al
    Fragility fracture and fear of falling in middle aged adults-a prevalence study.
    Osteoporos Int. 2024 Oct 10. doi: 10.1007/s00198-024-07166.
    PubMed    


  41. BORGSTROM F, Lorentzon M, Johansson H, Harvey NC, et al
    Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK.
    Osteoporos Int. 2024 Oct 4. doi: 10.1007/s00198-024-07251.
    PubMed     Abstract available


  42. SEO DH, Corr M, Patel S, Lui LY, et al
    Chemokine CXCL9, a marker of inflammaging, is associated with changes of muscle strength and mortality in older men.
    Osteoporos Int. 2024;35:1789-1796.
    PubMed     Abstract available


  43. SHARIFF JRR, Swe KM, Binkley N, Whyte MP, et al
    Skeletal fluorosis: an uncommon cause, yet a rescue treatment?
    Osteoporos Int. 2024;35:1859-1863.
    PubMed     Abstract available


    September 2024
  44. TAKEUCHI Y, Tanaka S, Kuroda T, Hagino H, et al
    Association between renal function and fracture incidence during treatment with teriparatide or alendronate: an exploratory subgroup analysis of the Japanese Osteoporosis Intervention Trial-05.
    Osteoporos Int. 2024 Sep 30. doi: 10.1007/s00198-024-07260.
    PubMed     Abstract available


  45. GIANGREGORIO LM, Alexiuk MR, Tangri N, Bohm C, et al
    Among people on osteoporosis medication, loss of appendicular or total body lean mass is an independent risk factor for hip and major osteoporotic fractures.
    Osteoporos Int. 2024 Sep 25. doi: 10.1007/s00198-024-07240.
    PubMed     Abstract available


  46. MASUDA S, Fukasawa T, Matsuda S, Yoshida S, et al
    Comparative effectiveness and cardiovascular safety of romosozumab versus teriparatide in patients with osteoporosis: a population-based cohort study.
    Osteoporos Int. 2024 Sep 25. doi: 10.1007/s00198-024-07255.
    PubMed     Abstract available


  47. VAN OOSTWAARD MM, Wyers CE, Driessen JHM, van Maren M, et al
    The risk of fragility fractures in men with prostate cancer treated with androgen deprivation therapy.
    Osteoporos Int. 2024 Sep 18. doi: 10.1007/s00198-024-07180.
    PubMed     Abstract available


  48. GHASEMINEJAD-RAEINI A, Azarboo A, Zareshahi N, Jalali S, et al
    Early-life famine exposure and risk of osteoporosis and low bone mineral density: a systematic review and meta-analysis.
    Osteoporos Int. 2024 Sep 13. doi: 10.1007/s00198-024-07250.
    PubMed     Abstract available


  49. ARMUTCU F, McCloskey E
    Insulin resistance, bone health, and fracture risk.
    Osteoporos Int. 2024 Sep 12. doi: 10.1007/s00198-024-07227.
    PubMed     Abstract available


  50. JAIN RK
    Comment on article "Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force Report on Clinical Algorithms for Fracture Risk".
    Osteoporos Int. 2024 Sep 4. doi: 10.1007/s00198-024-07242.
    PubMed    


  51. KHAN AN, Jones RB Jr, Khan N, Yang YX, et al
    Trends in hip fracture rates in US male veterans.
    Osteoporos Int. 2024 Sep 3. doi: 10.1007/s00198-024-07236.
    PubMed     Abstract available


  52. LUO Y, Zheng S, Jiang S, Yang G, et al
    B vitamins and bone health: a meta-analysis with trial sequential analysis of randomized controlled trials.
    Osteoporos Int. 2024;35:1645-1659.
    PubMed     Abstract available


  53. MAHMUD M, Muscatello DJ, Rahman MB, Osborne NJ, et al
    Association between socioeconomic deprivation and bone health status in the UK biobank cohort participants.
    Osteoporos Int. 2024;35:1573-1584.
    PubMed     Abstract available


    August 2024
  54. LIN CJ, Liu SJ, Lin KY
    Author response to OSIN-D-24-00958 comment on: the association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2024 Aug 29. doi: 10.1007/s00198-024-07201.
    PubMed    


  55. LI J, Zheng J
    Comment on: The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2024 Aug 29. doi: 10.1007/s00198-024-07200.
    PubMed    


  56. FAN Z, Zhao J, Chen J, Hu W, et al
    Causal associations of osteoporosis with stroke: a bidirectional Mendelian randomization study.
    Osteoporos Int. 2024 Aug 24. doi: 10.1007/s00198-024-07235.
    PubMed     Abstract available


  57. MITSUTAKE S, Lystad RP, Long JC, Braithwaite J, et al
    Correction: Group-based trajectories of potentially preventable hospitalisations among older adults after a hip fracture.
    Osteoporos Int. 2024 Aug 16. doi: 10.1007/s00198-024-07226.
    PubMed    


  58. ZHOU Q, Chen J
    Commentary on the Broader Perspectives of Hip Fractures in Primary Aldosteronism: From Medical to Social.
    Osteoporos Int. 2024 Aug 16. doi: 10.1007/s00198-024-07186.
    PubMed    


  59. JAIN RK, Polley E, Weiner M, Iwamaye A, et al
    An electronic health record (EHR)-based risk calculator can predict fractures comparably to FRAX: a proof-of-concept study.
    Osteoporos Int. 2024 Aug 15. doi: 10.1007/s00198-024-07221.
    PubMed     Abstract available


  60. TRAN TS, Bliuc D, Blank RD, Center JR, et al
    Fracture risk assessment in the presence of competing risk of death.
    Osteoporos Int. 2024 Aug 15. doi: 10.1007/s00198-024-07224.
    PubMed     Abstract available


  61. MCCARROLL K, Fitzpatrick D, Lannon R
    Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
    Osteoporos Int. 2024 Aug 9. doi: 10.1007/s00198-024-07218.
    PubMed    


  62. KUMAR S, Gild ML, McDonald MM, Kim AS, et al
    Author response to: OSIN-D-24-00849 Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
    Osteoporos Int. 2024 Aug 9. doi: 10.1007/s00198-024-07214.
    PubMed    


  63. ZENG Y, Yang Y, Wang J, Meng G, et al
    The Healing and therapeutic effects of perioperative bisphosphonate use in patients with fragility fractures: meta-analysis of 19 clinical trials.
    Osteoporos Int. 2024 Aug 8. doi: 10.1007/s00198-024-07191.
    PubMed     Abstract available


  64. GANDHAM A, Gregori G, Johansson L, Larsson BAM, et al
    Sarcopenia definitions and their association with injurious falls in older Swedish women from the Sahlgrenska University Hospital Prospective Evaluation of Risk of Bone fractures (SUPERB) study.
    Osteoporos Int. 2024 Aug 6. doi: 10.1007/s00198-024-07196.
    PubMed     Abstract available


  65. HADJI P, Kamali L, Thomasius F, Horas K, et al
    Real-world efficacy of a teriparatide biosimilar (RGB-10) compared with reference teriparatide on bone mineral density, trabecular bone score, and bone parameters assessed using quantitative ultrasound, 3D-SHAPER((R)) and high-resolution peripheral co
    Osteoporos Int. 2024 Aug 2. doi: 10.1007/s00198-024-07208.
    PubMed     Abstract available


  66. KIRK JM, Rathbun AM, Gruber-Baldini AL, Hochberg MC, et al
    Sex differences and predictors of anti-osteoporosis medication use in the 12 months after hip fracture surgery in adults 65 or older.
    Osteoporos Int. 2024 Aug 2. doi: 10.1007/s00198-024-07211.
    PubMed     Abstract available


    July 2024
  67. MITSUTAKE S, Lystad RP, Long JC, Braithwaite J, et al
    Group-based trajectories of potentially preventable hospitalisations among older adults after a hip fracture.
    Osteoporos Int. 2024 Jul 31. doi: 10.1007/s00198-024-07203.
    PubMed     Abstract available


  68. TAYLOR L, Matsunaga M, Ahn HJ, Siu AM, et al
    Risk factors associated with 1-year mortality after osteoporotic hip fracture in Hawai'i: higher mortality risk among Native Hawaiians and other Pacific Islanders.
    Osteoporos Int. 2024 Jul 30. doi: 10.1007/s00198-024-07195.
    PubMed     Abstract available


  69. MAZEDA C, Azevedo SF, Barcelos A
    What the American Society of Anesthesiologists classification scores tell us after a hip fracture?
    Osteoporos Int. 2024 Jul 26. doi: 10.1007/s00198-024-07199.
    PubMed    


  70. LE HV, Van BW, Shahzad H, Teng P, et al
    Fracture liaison service-a multidisciplinary approach to osteoporosis management.
    Osteoporos Int. 2024 Jul 18. doi: 10.1007/s00198-024-07181.
    PubMed     Abstract available


  71. SCHWARCZ Y, Yanover C, Rouach V, Luria S, et al
    Non-osteoporotic fractures are associated with increased risk of subsequent major osteoporotic fractures.
    Osteoporos Int. 2024 Jul 13. doi: 10.1007/s00198-024-07169.
    PubMed     Abstract available


  72. JOHANSSON P, Kristjansdottir HL, Johansson H, Mellstrom D, et al
    Increased risk of hip and major osteoporotic fractures in 8463 patients who have undergone stem cell transplantation, a Swedish population-based study.
    Osteoporos Int. 2024 Jul 8. doi: 10.1007/s00198-024-07171.
    PubMed     Abstract available


  73. MOBERG L, Jehpsson L, Nilsson PM, Rosengren B, et al
    Birth weight and birth length affect future fracture risk differently in men and women.
    Osteoporos Int. 2024 Jul 5. doi: 10.1007/s00198-024-07172.
    PubMed     Abstract available


  74. HEUSER L, Schoeneberg C, Rascher K, Lendemans S, et al
    Validation of the Geriatrics at Risk Score (GeRi-Score) on 120-day follow-up, the influence of preoperative geriatric visits, and the time to surgery on the outcome of hip fracture patients: an analysis from the Registry for Geriatric Trauma (ATR-DGU)
    Osteoporos Int. 2024 Jul 4. doi: 10.1007/s00198-024-07177.
    PubMed     Abstract available


  75. KANIS JA, Harvey NC, Lorentzon M, Liu E, et al
    Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk.
    Osteoporos Int. 2024 Jul 3. doi: 10.1007/s00198-024-07162.
    PubMed     Abstract available


  76. BENSKY MJ, Adler L, Banon T, Gabay L, et al
    Correction: Risk of major osteoporotic fractures among ultra-orthodox Jews.
    Osteoporos Int. 2024 Jul 2. doi: 10.1007/s00198-024-07174.
    PubMed    


  77. PARK SY, Ahn SH, Bae GH, Jang S, et al
    Low-dose glucocorticoid increase the risk of fracture in postmenopausal women with low bone mass: a retrospective cohort study.
    Osteoporos Int. 2024 Jul 2. doi: 10.1007/s00198-024-07159.
    PubMed     Abstract available


  78. KIMURA S, Sunouchi T, Watanabe S, Hoshino Y, et al
    Latent metabolic bone disease, skeletal dysplasia and other conditions related to low bone formation among 38 patients with subtrochanteric femoral fractures: a retrospective observational study.
    Osteoporos Int. 2024 Jul 1. doi: 10.1007/s00198-024-07168.
    PubMed     Abstract available


    June 2024
  79. HESTNES I, Solberg LB, Meyer HE, Sundet M, et al
    The hip fracture incidence in the high-risk area Oslo continues to decline.
    Osteoporos Int. 2024 Jun 26. doi: 10.1007/s00198-024-07156.
    PubMed     Abstract available


  80. HOLVIK K, Dahl C, Samuelsen SO, Sogaard AJ, et al
    Educational gradient in hip fracture incidence in Norway. The Norwegian Epidemiologic Osteoporosis Studies (NOREPOS).
    Osteoporos Int. 2024 Jun 25. doi: 10.1007/s00198-024-07133.
    PubMed     Abstract available


  81. BARZILAY JI, Buzkova P, Bielinski SJ, Cotch MF, et al
    The association of microvascular disease and endothelial dysfunction with vertebral trabecular bone mineral density : The MESA study.
    Osteoporos Int. 2024 Jun 24. doi: 10.1007/s00198-024-07152.
    PubMed     Abstract available


  82. MUZZAMMIL M, Bhura S, Hussain AS, Bashir S, et al
    Undiagnosed vertebral fragility fractures in patients with distal radius fragility fractures: an opportunity for prevention of morbimortality in osteoporotic patients in developing countries.
    Osteoporos Int. 2024 Jun 20. doi: 10.1007/s00198-024-07149.
    PubMed     Abstract available


  83. ZHAO AY, Ferraro S, Agarwal A, Mikula JD, et al
    Prior fragility fractures are associated with a higher risk of 8-year complications following total shoulder arthroplasty.
    Osteoporos Int. 2024 Jun 20. doi: 10.1007/s00198-024-07147.
    PubMed     Abstract available


  84. SO E, Juels C, Scott RT, Sietsema DL, et al
    A comparison of foot fractures relative to other fragility fractures: a review and analysis of the American Orthopaedic Association's Own the Bone Database.
    Osteoporos Int. 2024 Jun 18. doi: 10.1007/s00198-024-07153.
    PubMed     Abstract available


  85. MILTON-COLE R, Sheehan KJ
    Author response to: OSIN-D-24-00452, "Comment on: Effectiveness of exercise rehabilitation interventions on depressive symptoms in older adults post hip fracture: a systematic review and meta-analysis".
    Osteoporos Int. 2024 Jun 14. doi: 10.1007/s00198-024-07125.
    PubMed    


  86. WU H, Xiao H
    Comment on: Effectiveness of exercise rehabilitation interventions on depressive symptoms in older adults post hip fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2024 Jun 14. doi: 10.1007/s00198-024-07124.
    PubMed    


  87. XU MZ, Lu K, Ye YW, Xu SM, et al
    Sex differences in hemoglobin levels and five-year refracture risk in patients with osteoporotic fractures: a retrospective cohort analysis.
    Osteoporos Int. 2024 Jun 6. doi: 10.1007/s00198-024-07142.
    PubMed     Abstract available


  88. GKANIATSA E, Sandstrom TZ, Rosengren A, Trimpou P, et al
    Hip fractures in patients with primary aldosteronism - a Swedish nationwide study.
    Osteoporos Int. 2024 Jun 5. doi: 10.1007/s00198-024-07132.
    PubMed     Abstract available


  89. LAROSE G, Al-Azazi S, Lix LM, Bohm E, et al
    Introduction of an order set after hip fracture improves osteoporosis medication initiation and persistence: a population-based before-after analysis.
    Osteoporos Int. 2024 Jun 5. doi: 10.1007/s00198-024-07131.
    PubMed     Abstract available


  90. KUMAR S, Gild ML, McDonald MM, Kim AS, et al
    A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
    Osteoporos Int. 2024 Jun 5. doi: 10.1007/s00198-024-07139.
    PubMed     Abstract available


  91. CHARATCHAROENWITTHAYA N, Nimitphong H, Wattanachanya L, Songpatanasilp T, et al
    Epidemiology of hip fractures in Thailand.
    Osteoporos Int. 2024 Jun 4. doi: 10.1007/s00198-024-07140.
    PubMed     Abstract available


  92. TAHMASBI F, Sadoughi F, Sheikhtaheri A, Zabihiyeganeh M, et al
    Developing fracture liaison service framework based on comparative analysis and scoping review.
    Osteoporos Int. 2024 Jun 3. doi: 10.1007/s00198-024-07091.
    PubMed     Abstract available


  93. ZHOU L, Zhou H, Xu H, Sun X, et al
    Different bone health progression patterns and early-stage risk marker in glucocorticoid-treated ambulatory Duchenne muscular dystrophy.
    Osteoporos Int. 2024;35:997-1005.
    PubMed     Abstract available


    May 2024
  94. CHANDRASOMA D, Chiu S, Niddrie F, Major G, et al
    Should major trauma fractures be part of a fracture liaison service's remit: a cost-benefit estimate.
    Osteoporos Int. 2024 May 27. doi: 10.1007/s00198-024-07134.
    PubMed     Abstract available


  95. PARK YB, Kim M, Nam HC, Jeon JW, et al
    Total knee arthroplasty and periprosthetic distal femoral fracture: looking beyond the osteoporosis to previous osteoporotic fracture.
    Osteoporos Int. 2024 May 27. doi: 10.1007/s00198-024-07138.
    PubMed     Abstract available


  96. MENNEN AHM, Maas M, van Embden D
    Letter of rebuttal to 'Comment on: Imaging of pelvic ring fractures in older adults and its clinical implications-a systematic review'.
    Osteoporos Int. 2024 May 21. doi: 10.1007/s00198-024-07117.
    PubMed    


  97. ZHANG Y, Lu M, Wang L
    Comment on: imaging of pelvic ring fractures in older adults and its clinical implications-a systematic review.
    Osteoporos Int. 2024 May 21. doi: 10.1007/s00198-024-07107.
    PubMed    


  98. WANG X, Zhao X
    Letter to the Editor regarding "Associations between ultra-distal forearm bone mineral density and incident fracture in women".
    Osteoporos Int. 2024 May 20. doi: 10.1007/s00198-024-07098.
    PubMed    


  99. HOLLOWAY-KEW KL, Betson AG, Anderson KB, Kotowicz MA, et al
    Author Response to OSIN-D-24-00437: Letter to the Editor regarding "Associations between ultra-distal forearm bone mineral density and incident fracture in women".
    Osteoporos Int. 2024 May 20. doi: 10.1007/s00198-024-07094.
    PubMed    


  100. DAGNELIE PC, Willems PC, Jorgensen NR
    Nutritional status as independent prognostic factor of outcome and mortality until five years after hip fracture: a comprehensive prospective study.
    Osteoporos Int. 2024 May 17. doi: 10.1007/s00198-024-07088.
    PubMed     Abstract available


  101. ANSARI H, Jaglal S, Cheung AM, Jain R, et al
    Osteoporosis management in adults with schizophrenia following index hip fracture event: a 10-year population-based retrospective cohort study, Ontario, Canada.
    Osteoporos Int. 2024 May 17. doi: 10.1007/s00198-024-07123.
    PubMed     Abstract available


  102. TAKAKUBO Y, Miyaji T, Ota D, Takahashi T, et al
    Comment on Byun et al.: The effect of teriparatide on fracture healing after atypical femoral fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2024 May 15. doi: 10.1007/s00198-024-07116.
    PubMed    


  103. LIN CJ, Lee YS, Yeh JH, Liu SJ, et al
    The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2024 May 15. doi: 10.1007/s00198-024-07097.
    PubMed     Abstract available


  104. ALI A, Huszti E, Noordin S, Ali U, et al
    Examining treatment targets and equity in bone-active medication use within secondary fracture prevention: a systematic review and meta-analysis.
    Osteoporos Int. 2024 May 14. doi: 10.1007/s00198-024-07078.
    PubMed     Abstract available


  105. FUNAKOSHI Y, Maruyama K, Kato T, Saito I, et al
    Association of depressive symptoms with incident fractures: the Japan Public Health Center-based Prospective Study for the Next Generation (JPHC-NEXT).
    Osteoporos Int. 2024 May 11. doi: 10.1007/s00198-024-07106.
    PubMed     Abstract available


  106. KOBAYASHI T, Morimoto T, Ito K, Mawatari M, et al
    Denosumab vs. bisphosphonates in primary osteoporosis: a meta-analysis of comparative safety in randomized controlled trials.
    Osteoporos Int. 2024 May 11. doi: 10.1007/s00198-024-07118.
    PubMed     Abstract available


  107. XIAO X, Wu Q
    Enhanced fracture risk prediction: a novel multi-trait genetic approach integrating polygenic scores of fracture-related traits.
    Osteoporos Int. 2024 May 7. doi: 10.1007/s00198-024-07105.
    PubMed     Abstract available


  108. LIU B, Ng CY, La PBD, Wong P, et al
    Osteoporosis and fracture risk assessment in adults with ischaemic stroke.
    Osteoporos Int. 2024 May 4. doi: 10.1007/s00198-024-07099.
    PubMed     Abstract available


    April 2024
  109. PRAVEEN AD, Aspelund T, Ferguson SJ, Sigurethsson S, et al
    Refracture and mortality risk in the elderly with osteoporotic fractures: the AGES-Reykjavik study.
    Osteoporos Int. 2024 Apr 24. doi: 10.1007/s00198-024-07096.
    PubMed     Abstract available


  110. GOLD DT, Beckett T, Deal C, James AL, et al
    Treatment patterns in women with postmenopausal osteoporosis using abaloparatide: a real-world observational study.
    Osteoporos Int. 2024 Apr 24. doi: 10.1007/s00198-024-07070.
    PubMed     Abstract available


  111. WANG M, Seibel MJ
    Secondary fracture prevention in primary care: a narrative review.
    Osteoporos Int. 2024 Apr 23. doi: 10.1007/s00198-024-07036.
    PubMed     Abstract available


  112. AGARWAL AR, Kinnard MJ, Murdock C, Zhao AY, et al
    The cost-effectiveness of osteoporosis medications for preventing periprosthetic fractures following femoral neck fracture indicated hip arthroplasty: a break-even analysis.
    Osteoporos Int. 2024 Apr 15. doi: 10.1007/s00198-024-07085.
    PubMed     Abstract available


  113. ZUBICK P, Dahlke S
    Family/caregiver influence on osteoporosis management for older people: an integrative review.
    Osteoporos Int. 2024 Apr 15. doi: 10.1007/s00198-024-07081.
    PubMed     Abstract available


  114. WU J, Li J, Yan Z, Yu X, et al
    Higher prevalence of thyroid-specific autoantibodies (TPOAb and TgAb) is related to a higher prevalence of fractures in females: results from NHANES 2007-2010.
    Osteoporos Int. 2024 Apr 12. doi: 10.1007/s00198-024-07083.
    PubMed     Abstract available


  115. XIN Z, Xu H, Zhang X, Samelson EJ, et al
    Association of bone fracture with 30-year body mass index (BMI) trajectories: findings from the Framingham Heart Study : Bone fracture and 30-year BMI trajectories.
    Osteoporos Int. 2024 Apr 8. doi: 10.1007/s00198-024-07068.
    PubMed     Abstract available


  116. CHANDRAN M, Akesson KE, Javaid MK, Harvey N, et al
    Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review.
    Osteoporos Int. 2024 Apr 8. doi: 10.1007/s00198-024-07059.
    PubMed     Abstract available


  117. LEMS WF, van den Bergh JP, Geusens P
    Follow-up in Fracture Liaisons Services: the involvement of general practitioners and fracture nurses is urgently needed.
    Osteoporos Int. 2024 Apr 6. doi: 10.1007/s00198-024-07079.
    PubMed    


  118. LANE J, Langdahl B, Stone M, Kurth A, et al
    Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials.
    Osteoporos Int. 2024 Apr 4. doi: 10.1007/s00198-024-07049.
    PubMed     Abstract available


  119. GIELEN E, Aldven M, Kanis JA, Borgstrom F, et al
    Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium.
    Osteoporos Int. 2024 Apr 2. doi: 10.1007/s00198-024-07043.
    PubMed     Abstract available


  120. ANAGNOSTIS P, Lallas K, Pappa A, Avgeris G, et al
    The association of vasomotor symptoms with fracture risk and bone mineral density in postmenopausal women: a systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2024 Apr 2. doi: 10.1007/s00198-024-07075.
    PubMed     Abstract available


  121. WHITING PS, Hare K, Krueger D, Borchardt G, et al
    Periprosthetic fractures are osteoporotic fractures: missed opportunities for osteoporosis diagnosis.
    Osteoporos Int. 2024 Apr 1. doi: 10.1007/s00198-024-07057.
    PubMed     Abstract available


    March 2024
  122. KOBAYASHI T, Morimoto T, Mawatari M
    Factors influencing the measurement of sagittal spinopelvic alignment in patients with vertebral fractures.
    Osteoporos Int. 2024 Mar 29. doi: 10.1007/s00198-024-07063.
    PubMed    


  123. DANAZUMI MS, Lightbody N, Dermody G
    Effectiveness of fracture liaison service in reducing the risk of secondary fragility fractures in adults aged 50 and older: a systematic review and meta-analysis.
    Osteoporos Int. 2024 Mar 27. doi: 10.1007/s00198-024-07052.
    PubMed     Abstract available


  124. CAI Y, Jun G, Zhuang X
    Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian randomized study.
    Osteoporos Int. 2024 Mar 27. doi: 10.1007/s00198-023-07013.
    PubMed     Abstract available


  125. LORENTZON M, Litsne H, Axelsson KF
    The significance of recent fracture location for imminent risk of hip and vertebral fractures-a nationwide cohort study on older adults in Sweden.
    Osteoporos Int. 2024 Mar 23. doi: 10.1007/s00198-024-07072.
    PubMed     Abstract available


  126. LI D, Mao SS, Budoff MJ
    Trabecular bone mineral density as measured by thoracic vertebrae predicts incident hip and vertebral fractures: the multi-ethnic study of atherosclerosis.
    Osteoporos Int. 2024 Mar 22. doi: 10.1007/s00198-024-07040.
    PubMed     Abstract available


  127. PLUSKIEWICZ W, Tabor E
    The comments on manuscript entitled 'Major osteoporosis fracture prediction in type 2 diabetes: a derivation and comparison study'.
    Osteoporos Int. 2024 Mar 20. doi: 10.1007/s00198-024-07056.
    PubMed    


  128. MERLIJN T, Swart KMA, Niemeijer C, van der Horst HE, et al
    The yield of routine laboratory examination in osteoporosis evaluation in primary care.
    Osteoporos Int. 2024 Mar 18. doi: 10.1007/s00198-024-07042.
    PubMed     Abstract available


  129. TAGUCHI A
    Letters to the Editor for "Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study".
    Osteoporos Int. 2024 Mar 14. doi: 10.1007/s00198-024-07058.
    PubMed    


  130. CRANDALL CJ, Larson J, Shadyab AH, LeBoff MS, et al
    Physical function trajectory after wrist or lower arm fracture in postmenopausal women: results from the Women's Health Initiative Study.
    Osteoporos Int. 2024 Mar 9. doi: 10.1007/s00198-024-07050.
    PubMed     Abstract available


  131. CLARK P, Cruz-Priego GA, Rascon-Pacheco RA, Bremer A, et al
    Incidence of hip fractures in Mexico 2006-2019: increasing numbers but decreasing rates.
    Osteoporos Int. 2024 Mar 9. doi: 10.1007/s00198-024-07045.
    PubMed     Abstract available


  132. KAY RS, Ho L, Clement ND, Duckworth AD, et al
    The incidence of subsequent contralateral hip fracture and factors associated with increased risk: the IMPACT Contralateral Fracture Study.
    Osteoporos Int. 2024 Mar 6. doi: 10.1007/s00198-024-07039.
    PubMed     Abstract available


  133. HOLLOWAY-KEW KL, Betson AG, Anderson KB, Kotowicz MA, et al
    Associations between ultra-distal forearm bone mineral density and incident fracture in women.
    Osteoporos Int. 2024 Mar 6. doi: 10.1007/s00198-024-07041.
    PubMed     Abstract available


    February 2024
  134. LIPPUNER K, Kyuchukova M, Schwab P, Rizzoli R, et al
    Differences in femoral fracture localizations in men and women in Switzerland between 1998 and 2021-reversal of the secular trend?
    Osteoporos Int. 2024 Feb 24. doi: 10.1007/s00198-024-07016.
    PubMed     Abstract available


  135. PRAVEEN AD, Sollmann N, Baum T, Ferguson SJ, et al
    CT image-based biomarkers for opportunistic screening of osteoporotic fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2024 Feb 14. doi: 10.1007/s00198-024-07029.
    PubMed     Abstract available


  136. SCHENE MR, Willems HC, Driessen JHM, Vranken L, et al
    Physical performance and sarcopenia assessment in patients with a recent fracture visiting the Fracture Liaison Service.
    Osteoporos Int. 2024 Feb 13. doi: 10.1007/s00198-023-07009.
    PubMed     Abstract available


  137. XU L, Zhao T, Perry L, Frost SA, et al
    Return on investment of fracture liaison services: a systematic review and analysis.
    Osteoporos Int. 2024 Feb 1. doi: 10.1007/s00198-024-07027.
    PubMed     Abstract available


  138. CHATTARIS T, Yang L, Johansson H, Sahni S, et al
    Performance of FRAX in older adults with frailty: the Framingham Heart Study.
    Osteoporos Int. 2024;35:265-275.
    PubMed     Abstract available


    January 2024
  139. YU W, Guan WM, Hayashi D, Lin Q, et al
    Vertebral fracture severity assessment on anteroposterior radiographs with a new semi-quantitative technique.
    Osteoporos Int. 2024 Jan 31. doi: 10.1007/s00198-024-07024.
    PubMed     Abstract available


  140. CUNHA-SANTOS F, Augusto D, Pinto AS, Dinis SP, et al
    Predictors of atypical femoral fractures: experience of a Portuguese Fracture Liaison Service.
    Osteoporos Int. 2024 Jan 29. doi: 10.1007/s00198-024-07033.
    PubMed    


  141. SMITH TO, Brown O, Baxter MA
    Fear-avoidant beliefs and behaviours after upper limb fracture in older people: a systematic review and meta-ethnography.
    Osteoporos Int. 2024 Jan 27. doi: 10.1007/s00198-024-07030.
    PubMed     Abstract available


  142. SILVA FF, Machado GR, Ribeiro ACM, Bonfiglioli KR, et al
    Damaged bone microarchitecture by Trabecular Bone Score (TBS) and low appendicular muscle mass: main risk factors for vertebral and non-vertebral fractures in women with long-standing rheumatoid arthritis.
    Osteoporos Int. 2024 Jan 25. doi: 10.1007/s00198-024-07026.
    PubMed     Abstract available


  143. BENNETT MJ, Center JR, Perry L
    Establishing consensus recommendations for long-term osteoporosis care for patients who have attended an Australian fracture liaison service: a Delphi study.
    Osteoporos Int. 2024 Jan 25. doi: 10.1007/s00198-024-07014.
    PubMed     Abstract available


  144. IKI M, Fujimori K, Nakatoh S, Tamaki J, et al
    Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwi
    Osteoporos Int. 2024 Jan 24. doi: 10.1007/s00198-024-07023.
    PubMed     Abstract available


  145. JEON S, Yu D, Kim S, Kim SW, et al
    Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture.
    Osteoporos Int. 2024 Jan 23. doi: 10.1007/s00198-024-07025.
    PubMed     Abstract available


  146. CAO X, Keyak JH, Sigurdsson S, Zhao C, et al
    A new hip fracture risk index derived from FEA-computed proximal femur fracture loads and energies-to-failure.
    Osteoporos Int. 2024 Jan 22. doi: 10.1007/s00198-024-07015.
    PubMed     Abstract available


  147. BYUN SE, Kim H, Lee SY, Kim SM, et al
    Selective estrogen receptor modulators (SERMs) with vitamin D composite agent can prevent fracture better than SERMs treatment: based on the National Health Claims Database 2017-2019.
    Osteoporos Int. 2024 Jan 19. doi: 10.1007/s00198-024-07022.
    PubMed     Abstract available


  148. SKJODT MK, Nicolaes J, Smith CD, Olsen KR, et al
    Opportunistically identifiable vertebral fractures on routine radiological imaging predict mortality: observational cohort study.
    Osteoporos Int. 2024 Jan 18. doi: 10.1007/s00198-024-07017.
    PubMed     Abstract available


  149. VANDENPUT L, Johansson H, McCloskey EV, Liu E, et al
    A meta-analysis of previous falls and subsequent fracture risk in cohort studies.
    Osteoporos Int. 2024 Jan 17. doi: 10.1007/s00198-023-07012.
    PubMed     Abstract available


  150. LEUNG MTY, Turner JP, Marquina C, Ilomaki J, et al
    Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study.
    Osteoporos Int. 2024 Jan 10. doi: 10.1007/s00198-023-06974.
    PubMed     Abstract available


  151. CHOO YW, Mohd Tahir NA, Mohamed Said MS, Makmor Bakry M, et al
    Health-related quality of life in osteoporosis: a systematic review of measurement properties of the QUALEFFO-41.
    Osteoporos Int. 2024 Jan 9. doi: 10.1007/s00198-023-07005.
    PubMed     Abstract available


  152. MULKERRIN P, O'Shea F, Fitzgerald G
    Comment on: Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis.
    Osteoporos Int. 2024 Jan 8. doi: 10.1007/s00198-023-07010.
    PubMed    


  153. BHATTACHARYA S, Nagendra L, Chandran M, Kapoor N, et al
    Trabecular bone score in adults with type 1 diabetes: a meta-analysis.
    Osteoporos Int. 2024;35:105-115.
    PubMed     Abstract available


    December 2023
  154. YOKOYAMA K, Ikeda N, Tanaka H, Ito Y, et al
    Changes in spinal sagittal balance after a new osteoporotic vertebral compression fracture.
    Osteoporos Int. 2023 Dec 18. doi: 10.1007/s00198-023-06976.
    PubMed     Abstract available


  155. YOO JE, Huh Y, Kim E, Park SH, et al
    Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study.
    Osteoporos Int. 2023 Dec 14. doi: 10.1007/s00198-023-06983.
    PubMed     Abstract available


  156. ANDREASEN C, Dahl C, Solberg LB, Borgen TT, et al
    Epidemiology of forearm fractures in women and men in Norway 2008-2019.
    Osteoporos Int. 2023 Dec 12. doi: 10.1007/s00198-023-06990.
    PubMed     Abstract available


  157. ZHOU YF, Wang J, Wang XL, Song SS, et al
    A prediction model of elderly hip fracture mortality including preoperative red cell distribution width constructed based on the random survival forest (RSF) and Cox risk ratio regression.
    Osteoporos Int. 2023 Dec 7. doi: 10.1007/s00198-023-06988.
    PubMed     Abstract available


  158. HASSANABADI N, Berger C, Papaioannou A, Cheung AM, et al
    Geographic variation in bone mineral density and prevalent fractures in the Canadian longitudinal study on aging.
    Osteoporos Int. 2023 Dec 2. doi: 10.1007/s00198-023-06975.
    PubMed     Abstract available


    November 2023
  159. HOU XL, Liu JY, Fan XH, Zhang N, et al
    Correction to: Secular trends of incidence and hospitalization cost of hip fracture in Tangshan, China.
    Osteoporos Int. 2023 Nov 30. doi: 10.1007/s00198-023-06987.
    PubMed    


  160. PERIS P, Blasco J, Monegal A, Florez H, et al
    Effect of gender on the evolution of pain and quality of life after treatment of symptomatic vertebral fragility fractures.
    Osteoporos Int. 2023 Nov 30. doi: 10.1007/s00198-023-06960.
    PubMed     Abstract available


  161. BUI M, Nijmeijer WS, Hegeman JH, Witteveen A, et al
    Systematic review and meta-analysis of preoperative predictors for early mortality following hip fracture surgery.
    Osteoporos Int. 2023 Nov 24. doi: 10.1007/s00198-023-06942.
    PubMed     Abstract available


  162. BEAUDART C, Sharma M, Clark P, Fujiwara S, et al
    Patients' preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study.
    Osteoporos Int. 2023 Nov 13. doi: 10.1007/s00198-023-06955.
    PubMed     Abstract available


  163. KONNOPKA C, Buchele G, Jaensch A, Rothenbacher D, et al
    Evaluation of costs, osteoporosis treatment, and re-fractures in German collaborative orthogeriatric care after fragility fractures.
    Osteoporos Int. 2023 Nov 9. doi: 10.1007/s00198-023-06965.
    PubMed     Abstract available


  164. AGARWAL AR, Tarawneh O, Cohen JS, Gu A, et al
    The incremental risk of fragility fractures in aging men.
    Osteoporos Int. 2023 Nov 8. doi: 10.1007/s00198-023-06956.
    PubMed     Abstract available


  165. JAVAID MK, Calo M, Wullich S, Mohsin Z, et al
    Development, implementation and evaluation of a multinational FLS mentorship programme in Latin America.
    Osteoporos Int. 2023;34:1881-1891.
    PubMed     Abstract available


    October 2023
  166. HALL AJ, Clement ND, MacLullich AMJ, White TO, et al
    Vaccination against COVID-19 reduced the mortality risk of COVID-positive hip fracture patients to baseline levels: the nationwide data-linked IMPACT Protect study.
    Osteoporos Int. 2023 Oct 28. doi: 10.1007/s00198-023-06954.
    PubMed     Abstract available


  167. HAN S, Kim S, Yeh EJ, Suh HS, et al
    Understanding the long-term impact of incident osteoporotic fractures on healthcare utilization and costs in Korean postmenopausal women.
    Osteoporos Int. 2023 Oct 25. doi: 10.1007/s00198-023-06934.
    PubMed     Abstract available


  168. INPAN R, Na Takuathung M, Sakuludomkan W, Dukaew N, et al
    Isoflavone intervention and its impact on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
    Osteoporos Int. 2023 Oct 25. doi: 10.1007/s00198-023-06944.
    PubMed     Abstract available


  169. LOSCALZO E, See J, Bharill S, Yousefzadeh N, et al
    Growth hormone and testosterone delay vertebral fractures in boys with muscular dystrophy on chronic glucocorticoids.
    Osteoporos Int. 2023 Oct 23. doi: 10.1007/s00198-023-06951.
    PubMed     Abstract available


  170. MITCHELL DM, Singhal V, Nimmala S, Lauze M, et al
    Risk of wrist fracture, estimated by the load-to-strength ratio, declines following sleeve gastrectomy in adolescents and young adults.
    Osteoporos Int. 2023 Oct 21. doi: 10.1007/s00198-023-06941.
    PubMed     Abstract available


  171. KYVERNITAKIS I, Reuter TC, Hellmeyer L, Hars O, et al
    Correction to: Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up.
    Osteoporos Int. 2023 Oct 19. doi: 10.1007/s00198-023-06927.
    PubMed    


  172. ZERAATTALAB-MOTLAGH S, Mortazavi AS, Ghoreishy SM, Mohammadi H, et al
    Association between total and animal proteins with risk of fracture: A systematic review and dose-response meta-analysis of cohort studies.
    Osteoporos Int. 2023 Oct 19. doi: 10.1007/s00198-023-06948.
    PubMed     Abstract available


  173. MILTON-COLE R, Kazeem K, Gibson A, Guerra S, et al
    Effectiveness of exercise rehabilitation interventions on depressive symptoms in older adults post hip fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2023 Oct 13. doi: 10.1007/s00198-023-06923.
    PubMed     Abstract available


  174. PLAIS N, Bustos JG, Mahillo-Fernandez I, Tome-Bermejo F, et al
    Osteoporotic vertebral fractures localized in the lumbar area significantly impact sagittal alignment.
    Osteoporos Int. 2023 Oct 13. doi: 10.1007/s00198-023-06936.
    PubMed     Abstract available


  175. REILAND K, Haastert B, Arend W, Kluppelholz B, et al
    Epidemiology of distal radius fractures in Germany - incidence rates and trends based on inpatient and outpatient data.
    Osteoporos Int. 2023 Oct 11. doi: 10.1007/s00198-023-06904.
    PubMed     Abstract available


  176. YAN F, Wu L, Lang J, Huang Z, et al
    Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis.
    Osteoporos Int. 2023 Oct 9. doi: 10.1007/s00198-023-06925.
    PubMed     Abstract available


  177. TARALDSEN K, Polhemus A, Engdal M, Jansen CP, et al
    Evaluation of mobility recovery after hip fracture: a scoping review of randomized controlled studies.
    Osteoporos Int. 2023 Oct 6. doi: 10.1007/s00198-023-06922.
    PubMed     Abstract available


  178. LI N, van den Bergh JP, Boonen A, Wyers CE, et al
    Cost-effectiveness analysis of fracture liaison services: a Markov model using Dutch real-world data.
    Osteoporos Int. 2023 Oct 3. doi: 10.1007/s00198-023-06924.
    PubMed     Abstract available


  179. OTEO-ALVARO A, Garcia CG, Sanchez AI, Santamaria CA, et al
    Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS).
    Osteoporos Int. 2023;34:1799-1804.
    PubMed     Abstract available


    September 2023
  180. MAAS L, Raskin N, van Onna M, Cornelissen D, et al
    Development and usability of a decision aid to initiate anti-osteoporosis medication treatment in patients visiting the fracture liaison service with a recent fracture.
    Osteoporos Int. 2023 Sep 21. doi: 10.1007/s00198-023-06906.
    PubMed     Abstract available


  181. HUNG WC, Lin YL, Cheng TT, Chin WL, et al
    Establish and validate the reliability of predictive models in bone mineral density by deep learning as examination tool for women.
    Osteoporos Int. 2023 Sep 20. doi: 10.1007/s00198-023-06913.
    PubMed     Abstract available


  182. LIU X, Makaroff KE, Almario CV, Khalil C, et al
    Determining patient preferences for the medical management of osteoporosis using conjoint analysis.
    Osteoporos Int. 2023 Sep 18. doi: 10.1007/s00198-023-06882.
    PubMed     Abstract available


  183. ELWAKIL W, El Gaafary M, El Miedany Y
    Screening and management of osteoporosis: a survey of knowledge, attitude, and practice among healthcare professionals in Egypt-a study by the Egyptian Academy of Bone Health.
    Osteoporos Int. 2023 Sep 18. doi: 10.1007/s00198-023-06914.
    PubMed     Abstract available


  184. FENG JN, Zhang CG, Li BH, Zhan SY, et al
    Global burden of hip fracture: The Global Burden of Disease Study.
    Osteoporos Int. 2023 Sep 14. doi: 10.1007/s00198-023-06907.
    PubMed     Abstract available


  185. CLIFTON GOLDNEY D, Pelegrin C, Jerkovich F, Longobardi V, et al
    Twenty-four months of follow-up in women with rebound-associated vertebral fractures after discontinuation of denosumab: a single-centre case series.
    Osteoporos Int. 2023 Sep 13. doi: 10.1007/s00198-023-06894.
    PubMed     Abstract available


  186. LU K, Wu YM, Shi Q, Gong YQ, et al
    A novel fracture liaison service using digital health: impact on mortality in hospitalized elderly osteoporotic fracture patients.
    Osteoporos Int. 2023 Sep 12. doi: 10.1007/s00198-023-06905.
    PubMed     Abstract available


  187. WANG X, Zhang F, Zhang Y, Zhang J, et al
    Effect of SGLT2 inhibitors on fractures, BMD, and bone metabolism markers in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
    Osteoporos Int. 2023 Sep 11. doi: 10.1007/s00198-023-06908.
    PubMed     Abstract available


  188. NICOLAES J, Liu Y, Zhao Y, Huang P, et al
    External validation of a convolutional neural network algorithm for opportunistically detecting vertebral fractures in routine CT scans.
    Osteoporos Int. 2023 Sep 7. doi: 10.1007/s00198-023-06903.
    PubMed     Abstract available


  189. RAUF MA, Kotecha J, Moss K
    Reducing diagnostic delay in hypophosphatasia: a case series of 14 patients presenting to general rheumatology.
    Osteoporos Int. 2023;34:1647-1652.
    PubMed     Abstract available


    August 2023
  190. MOAYYERI A, Warden J, Han S, Suh HS, et al
    Estimating the economic burden of osteoporotic fractures in a multinational study: a real-world data perspective.
    Osteoporos Int. 2023 Aug 31. doi: 10.1007/s00198-023-06895.
    PubMed     Abstract available


  191. BILLINGTON EO, Miyagishima RC, Hasselaar C, Arain M, et al
    Women's perspectives regarding osteoporosis, fracture risk, and pharmacologic treatment: a cross-sectional study.
    Osteoporos Int. 2023 Aug 22. doi: 10.1007/s00198-023-06890.
    PubMed     Abstract available


  192. BARCELOS A, Goncalves J, Mateus C, Canhao H, et al
    Costs of incident non-hip osteoporosis-related fractures in postmenopausal women from a payer perspective.
    Osteoporos Int. 2023 Aug 19. doi: 10.1007/s00198-023-06881.
    PubMed     Abstract available


  193. HONG N, Shin S, Lee S, Rhee Y, et al
    Romosozumab is associated with greater trabecular bone score improvement compared to denosumab in postmenopausal osteoporosis.
    Osteoporos Int. 2023 Aug 19. doi: 10.1007/s00198-023-06889.
    PubMed     Abstract available


  194. EVERTS-GRABER J, Bonel H, Lehmann D, Gahl B, et al
    Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study.
    Osteoporos Int. 2023 Aug 18. doi: 10.1007/s00198-023-06887.
    PubMed    


  195. TURABI RY, Sheehan KJ
    Response letter to: "The importance of structural barriers of osteoporotic hip fracture in the elderly".
    Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06864.
    PubMed    


  196. MEIJIDE H, Gredilla I, Cachorro I, Robert I, et al
    The importance of structural barriers of osteoporotic hip fracture in the elderly.
    Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06875.
    PubMed    


  197. KANIS JA, Johansson H, McCloskey EV, Liu E, et al
    Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX.
    Osteoporos Int. 2023 Aug 11. doi: 10.1007/s00198-023-06870.
    PubMed     Abstract available


  198. SKULADOTTIR SS, Hjaltadottir I, Launer L, Cotch MF, et al
    Milk intake and hip fracture incidence in community-dwelling old Icelandic adults.
    Osteoporos Int. 2023 Aug 10. doi: 10.1007/s00198-023-06883.
    PubMed     Abstract available


  199. SEO DH, Jeong Y, Cho Y, Kim SH, et al
    Age- and dose-dependent effect of statin use on the risk of osteoporotic fracture in older adults.
    Osteoporos Int. 2023 Aug 8. doi: 10.1007/s00198-023-06879.
    PubMed     Abstract available


  200. DOUSSIERE M, Jesson C, Diep L, Menis J, et al
    Clinical and biological parameters associated with fracture recurrence according to fracture liaison service dataset.
    Osteoporos Int. 2023 Aug 8. doi: 10.1007/s00198-023-06868.
    PubMed     Abstract available


  201. FITZPATRICK D, Lannon R, Laird E, Ward M, et al
    The association between proton pump inhibitors and hyperparathyroidism: a potential mechanism for increased fracture-results of a large observational cohort study.
    Osteoporos Int. 2023 Aug 2. doi: 10.1007/s00198-023-06867.
    PubMed     Abstract available


  202. FITZPATRICK D, Seebah S, Lannon R, Mc Carroll K, et al
    Atypical femoral fracture after denosumab for the treatment of osteoporosis in bisphosphonate naive patients: two further cases.
    Osteoporos Int. 2023 Aug 1. doi: 10.1007/s00198-023-06869.
    PubMed    


  203. ZITTERMANN A, Schmidt A, Haardt J, Kalotai N, et al
    Protein intake and bone health: an umbrella review of systematic reviews for the evidence-based guideline of the German Nutrition Society.
    Osteoporos Int. 2023;34:1335-1353.
    PubMed     Abstract available


    July 2023
  204. EVERTS-GRABER J, Bonel H, Lehmann D, Gahl B, et al
    Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study.
    Osteoporos Int. 2023 Jul 26. doi: 10.1007/s00198-023-06863.
    PubMed     Abstract available


  205. THERKILDSEN J, Rohde PD, Nissen L, Thygesen J, et al
    A genome-wide genomic score added to standard recommended stratification tools does not improve the identification of patients with very low bone mineral density.
    Osteoporos Int. 2023 Jul 26. doi: 10.1007/s00198-023-06857.
    PubMed     Abstract available


  206. TSAI YL, Wu CH, Li CC, Shih CA, et al
    Drug adherence and treatment duration for denosumab and mortality risk among hip fracture patients.
    Osteoporos Int. 2023 Jul 19. doi: 10.1007/s00198-023-06845.
    PubMed     Abstract available


  207. SCHUMM AK, Craige EA, Arora NK, Owen PJ, et al
    Does adding exercise or physical activity to pharmacological osteoporosis therapy in patients with increased fracture risk improve bone mineral density and lower fracture risk? A systematic review and meta-analysis.
    Osteoporos Int. 2023 Jul 11. doi: 10.1007/s00198-023-06829.
    PubMed     Abstract available


  208. JAVAID MK, Pinedo-Villanueva R, Shah A, Mohsin Z, et al
    The Capture the Fracture(R) Partnership: an overview of a global initiative to increase the secondary fracture prevention care for patient benefit.
    Osteoporos Int. 2023 Jul 7. doi: 10.1007/s00198-023-06759.
    PubMed     Abstract available


  209. SHEVROJA E, Reginster JY, Lamy O, Al-Daghri N, et al
    Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Dis
    Osteoporos Int. 2023 Jul 1. doi: 10.1007/s00198-023-06817.
    PubMed     Abstract available


    June 2023
  210. SCHOUSBOE JT, Binkley N, Leslie WD
    Liver enzyme inducing anticonvulsant drug use is associated with prevalent vertebral fracture.
    Osteoporos Int. 2023 Jun 28. doi: 10.1007/s00198-023-06820.
    PubMed     Abstract available


  211. ZHANG X, Yang M, Zhang J, Ye P, et al
    Establishing a Chinese older hip fracture registry for older patients: a Delphi study to define the focus and key variables for this registry.
    Osteoporos Int. 2023 Jun 21. doi: 10.1007/s00198-023-06832.
    PubMed     Abstract available


  212. YEH EJ, Rajkovic-Hooley O, Silvey M, Ambler WS, et al
    Impact of fragility fractures on activities of daily living and productivity in community-dwelling women: a multi-national study.
    Osteoporos Int. 2023 Jun 19. doi: 10.1007/s00198-023-06822.
    PubMed     Abstract available


  213. GADGAARD NR, Varnum C, Nelissen RGHH, Vandenbroucke-Grauls C, et al
    Comorbidity and risk of infection among patients with hip fracture: a Danish population-based cohort study.
    Osteoporos Int. 2023 Jun 17. doi: 10.1007/s00198-023-06823.
    PubMed     Abstract available


  214. HAGINO H, Moriwaki K, Wada T, Osaki M, et al
    Urinary pentosidine level is associated with the risk of fracture in community-dwelling older adults: a prospective observational study.
    Osteoporos Int. 2023 Jun 8. doi: 10.1007/s00198-023-06816.
    PubMed     Abstract available


  215. HESARI E, Sanjari M, Mansourzadeh MJ, Fahimfar N, et al
    Osteoporosis medication adherence tools: a systematic review.
    Osteoporos Int. 2023 Jun 8. doi: 10.1007/s00198-023-06789.
    PubMed     Abstract available


  216. MENNEN AHM, Blokland AS, Maas M, van Embden D, et al
    Imaging of pelvic ring fractures in older adults and its clinical implications-a systematic review.
    Osteoporos Int. 2023 Jun 7. doi: 10.1007/s00198-023-06812.
    PubMed     Abstract available


    May 2023
  217. LU K, Wu YM, Shi Q, Gong YQ, et al
    The impact of acute-phase reaction on mortality and re-fracture after zoledronic acid in hospitalized elderly osteoporotic fracture patients.
    Osteoporos Int. 2023 May 29. doi: 10.1007/s00198-023-06803.
    PubMed     Abstract available


  218. CHATTARIS T, Chahal K, Berry SD
    Factors besides frailty index affect length of stay in older patients with hip fractures.
    Osteoporos Int. 2023 May 29:1-2. doi: 10.1007/s00198-023-06798.
    PubMed    


  219. GOLD LS, Suri P, O'Reilly MK, Kallmes DF, et al
    Mortality among older adults with osteoporotic vertebral fracture.
    Osteoporos Int. 2023 May 26. doi: 10.1007/s00198-023-06796.
    PubMed     Abstract available


  220. KWON H, Han KD, Kim BS, Moon SJ, et al
    Acromegaly and the long-term fracture risk of the vertebra and hip: a national cohort study.
    Osteoporos Int. 2023 May 24. doi: 10.1007/s00198-023-06800.
    PubMed     Abstract available


  221. KONDAPALLI AV, Kamanda-Kosseh M, Williams JM, Shiau S, et al
    Clinical characteristics of pregnancy and lactation associated osteoporosis: An online survey study.
    Osteoporos Int. 2023 May 19. doi: 10.1007/s00198-023-06793.
    PubMed     Abstract available


  222. YANG H, Bai J, Li L, Yang Y, et al
    Association of C-peptide level with bone mineral density in type 2 diabetes mellitus.
    Osteoporos Int. 2023 May 19. doi: 10.1007/s00198-023-06785.
    PubMed     Abstract available


  223. KONG SH, Kim S, Kim Y, Kim JH, et al
    Development and validation of common data model-based fracture prediction model using machine learning algorithm.
    Osteoporos Int. 2023 May 17. doi: 10.1007/s00198-023-06787.
    PubMed     Abstract available


  224. AGARWAL AR, Cohen JS, Tarawneh OH, Gu A, et al
    The impact of prior fragility fractures on long-term periprosthetic fracture risk following total knee arthroplasty.
    Osteoporos Int. 2023 May 11. doi: 10.1007/s00198-023-06746.
    PubMed     Abstract available


  225. AVGERINOU C, Petersen I, Clegg A, West RM, et al
    Trends in incidence of recorded diagnosis of osteoporosis, osteopenia, and fragility fractures in people aged 50 years and above: retrospective cohort study using UK primary care data.
    Osteoporos Int. 2023 May 10. doi: 10.1007/s00198-023-06739.
    PubMed     Abstract available


  226. METRAILLER A, Hans D, Lamy O, Gonzalez Rodriguez E, et al
    Heel quantitative ultrasound (QUS) predicts incident fractures independently of trabecular bone score (TBS), bone mineral density (BMD), and FRAX: the OsteoLaus Study.
    Osteoporos Int. 2023 May 8. doi: 10.1007/s00198-023-06728.
    PubMed     Abstract available


    April 2023
  227. MYUNG SK, Cho H
    Effects of intermittent or single high-dose vitamin D supplementation on risk of falls and fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2023 Apr 29. doi: 10.1007/s00198-023-06761.
    PubMed     Abstract available


  228. ZEELENBERG ML, Den Hartog D, Panneman MJM, Polinder S, et al
    Trends in incidence, health care consumption, and costs for proximal femoral fractures in the Netherlands between 2000 and 2019: a nationwide study.
    Osteoporos Int. 2023 Apr 29. doi: 10.1007/s00198-023-06774.
    PubMed     Abstract available


  229. RISKA BSL, Gunnes N, Stigum H, Finnes TE, et al
    Time-varying exposure to anti-osteoporosis drugs and risk of first-time hip fracture: a population wide study within the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS).
    Osteoporos Int. 2023 Apr 27. doi: 10.1007/s00198-023-06752.
    PubMed     Abstract available


  230. LEE RH, Bain J, Muehlbauer M, Ilkayeva O, et al
    Metabolic factors associated with incident fracture among older adults with type 2 diabetes mellitus: a nested case-control study.
    Osteoporos Int. 2023 Apr 26. doi: 10.1007/s00198-023-06763.
    PubMed     Abstract available


  231. BYUN SE, Lee KJ, Shin WC, Moon NH, et al
    The effect of teriparatide on fracture healing after atypical femoral fracture: A systematic review and meta-analysis.
    Osteoporos Int. 2023 Apr 25. doi: 10.1007/s00198-023-06768.
    PubMed     Abstract available


  232. SOLAIMAN RH, Irfanullah E, Navarro SM, Keil EJ, et al
    Rising incidence of stair-related upper extremity fractures among older adults in the United States: a 10-year nationwide analysis.
    Osteoporos Int. 2023 Apr 24:1-8. doi: 10.1007/s00198-023-06769.
    PubMed     Abstract available


  233. BENNETT MJ, Center JR, Perry L
    Exploring barriers and opportunities to improve osteoporosis care across the acute-to-primary care interface: a qualitative study.
    Osteoporos Int. 2023 Apr 24. doi: 10.1007/s00198-023-06748.
    PubMed     Abstract available


  234. TSUTSUI T, Fujiwara T, Matsumoto Y, Kimura A, et al
    Geriatric nutritional risk index as the prognostic factor in older patients with fragility hip fractures.
    Osteoporos Int. 2023 Apr 17. doi: 10.1007/s00198-023-06753.
    PubMed     Abstract available


  235. PONZANO M, Tibert N, Brien S, Funnell L, et al
    Publisher Correction: International consensus on the non-pharmacological and non-surgical management of osteoporotic vertebral fractures.
    Osteoporos Int. 2023 Apr 10. doi: 10.1007/s00198-023-06717.
    PubMed    


  236. YANG T, Wu J, Ding X, Zhou B, et al
    The association of melatonin use and hip fracture: a matched cohort study.
    Osteoporos Int. 2023 Apr 10. doi: 10.1007/s00198-023-06740.
    PubMed     Abstract available


  237. ICONARU L, Charles A, Baleanu F, Moreau M, et al
    Selection for treatment of patients at high risk of fracture by the short versus long term prediction models - data from the Belgian FRISBEE cohort.
    Osteoporos Int. 2023 Apr 6. doi: 10.1007/s00198-023-06737.
    PubMed     Abstract available


  238. TURABI RY, Wyatt D, Guerra S, O'Connell MDL, et al
    Barriers and facilitators of weight bearing after hip fracture surgery among older adults. A scoping review.
    Osteoporos Int. 2023 Apr 4. doi: 10.1007/s00198-023-06735.
    PubMed     Abstract available


  239. KHAN AA, AbuAlrob H, Al-Alwani H, Ali DS, et al
    Post hip fracture orthogeriatric care-a Canadian position paper addressing challenges in care and strategies to meet quality indicators.
    Osteoporos Int. 2023 Apr 4. doi: 10.1007/s00198-022-06640.
    PubMed     Abstract available


  240. TANG Y, Zhang L, Ye D, Zhao A, et al
    Causal relationship between Type 1 diabetes and osteoporosis and fracture occurrence: a two-sample Mendelian randomization analysis.
    Osteoporos Int. 2023 Apr 3. doi: 10.1007/s00198-023-06734.
    PubMed     Abstract available


    March 2023
  241. GOEL H, Binkley N, Hans D, Leslie WD, et al
    Bone density and trabecular bone score to predict fractures in adults aged 20-39 years: a registry-based study.
    Osteoporos Int. 2023 Mar 31. doi: 10.1007/s00198-023-06722.
    PubMed     Abstract available


  242. BAILLET M, Morello R, Vittecoq O, Chavoix C, et al
    Bone, cognitive, and anthropometric profiles and their relation to fracture sites in fallers: a cross-sectional study.
    Osteoporos Int. 2023 Mar 24. doi: 10.1007/s00198-023-06701.
    PubMed     Abstract available


  243. BINKLEY N, Nickel B, Anderson PA
    Periprosthetic fractures: an unrecognized osteoporosis crisis.
    Osteoporos Int. 2023 Mar 20. doi: 10.1007/s00198-023-06695.
    PubMed     Abstract available


  244. BRUHN R, Pedersen AB, Heide-Jorgensen U, Ehrenstein V, et al
    Epidemiology of male osteoporosis in Denmark (1996-2018).
    Osteoporos Int. 2023 Mar 13. doi: 10.1007/s00198-023-06720.
    PubMed     Abstract available


  245. SCHOENEBERG C, Heuser L, Rascher K, Lendemans S, et al
    The Geriatrics at Risk Score (GeRi-Score) for mortality prediction in geriatric patients with proximal femur fracture - a development and validation study from the Registry for Geriatric Trauma (ATR-DGU).
    Osteoporos Int. 2023 Mar 9. doi: 10.1007/s00198-023-06719.
    PubMed     Abstract available


  246. EISMAN JA, Cortet B, Boolell M, Ionescu-Ittu R, et al
    Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA.
    Osteoporos Int. 2023 Mar 6. doi: 10.1007/s00198-022-06627.
    PubMed     Abstract available


  247. WALSH ME, Cunningham C, Brent L, Savin B, et al
    Long-term outcome collection after hip fracture in Ireland: a systematic review of traditional and grey literature.
    Osteoporos Int. 2023 Mar 4. doi: 10.1007/s00198-023-06713.
    PubMed     Abstract available


  248. TALEVSKI J, Gianoudis J, Bailey CA, Ebeling PR, et al
    Effects of an 18-month community-based, multifaceted, exercise program on patient-reported outcomes in older adults at risk of fracture: secondary analysis of a randomised controlled trial.
    Osteoporos Int. 2023 Mar 2. doi: 10.1007/s00198-023-06693.
    PubMed     Abstract available


  249. HANS D, McDermott M, Huang S, Kim M, et al
    Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness-adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-label extension.
    Osteoporos Int. 2023 Mar 2. doi: 10.1007/s00198-023-06708.
    PubMed     Abstract available


  250. NIJMEIJER WS, Voorthuis BJ, Groothuis-Oudshoorn CGM, Wurdemann FS, et al
    The prediction of early mortality following hip fracture surgery in patients aged 90 years and older: the Almelo Hip Fracture Score 90 (AHFS(90)).
    Osteoporos Int. 2023 Mar 1. doi: 10.1007/s00198-023-06696.
    PubMed     Abstract available


    February 2023
  251. JUNG SY, Cho EB, Han KD, Jung JH, et al
    Risk of fracture in neuromyelitis optica spectrum disorder and multiple sclerosis: a nationwide cohort study in South Korea.
    Osteoporos Int. 2023 Feb 28. doi: 10.1007/s00198-023-06715.
    PubMed     Abstract available


  252. HE D, Pan C, Zhao Y, Wei W, et al
    Exome-wide screening identifies novel rare risk variants for bone mineral density.
    Osteoporos Int. 2023 Feb 28. doi: 10.1007/s00198-023-06710.
    PubMed     Abstract available


  253. XIAO X, Wu Q
    Ethnic disparities in fracture risk assessment using polygenic scores.
    Osteoporos Int. 2023 Feb 25. doi: 10.1007/s00198-023-06712.
    PubMed     Abstract available


  254. PONZANO M, Tibert N, Brien S, Funnell L, et al
    International consensus on the non-pharmacological and non-surgical management of osteoporotic vertebral fractures.
    Osteoporos Int. 2023 Feb 17. doi: 10.1007/s00198-023-06688.
    PubMed     Abstract available


  255. ABDALBARY M, Chishti E, Shakhashiro M, Mohamed R, et al
    Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study.
    Osteoporos Int. 2023 Feb 15. doi: 10.1007/s00198-023-06686.
    PubMed     Abstract available


  256. TORDJMAN K, Rouach V, Jaffe A, Givon A, et al
    Lower incidence of hip fractures among elderly Ethiopian immigrants to Israel: first assessment from the Israel National Trauma Registry (INTR) 2011-2020.
    Osteoporos Int. 2023 Feb 13. doi: 10.1007/s00198-023-06698.
    PubMed     Abstract available


  257. NURMI-LUTHJE I, Tiihonen R, Paattiniemi EL, Sarkkinen H, et al
    Correction to: Author response to the comments on our article Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up.
    Osteoporos Int. 2023 Feb 8. doi: 10.1007/s00198-023-06691.
    PubMed    


  258. LIN M, Wen X, Huang Z, Huang W, et al
    A nomogram for predicting residual low back pain after percutaneous kyphoplasty in osteoporotic vertebral compression fractures.
    Osteoporos Int. 2023 Feb 4. doi: 10.1007/s00198-023-06681.
    PubMed     Abstract available


  259. CHANDRAN M, Brind'Amour K, Fujiwara S, Ha YC, et al
    Prevalence of osteoporosis and incidence of related fractures in developed economies in the Asia Pacific region: a systematic review.
    Osteoporos Int. 2023 Feb 3. doi: 10.1007/s00198-022-06657.
    PubMed     Abstract available


  260. YE C, Lee K, Leslie WD, Lin M, et al
    Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event.
    Osteoporos Int. 2023 Feb 2. doi: 10.1007/s00198-023-06690.
    PubMed     Abstract available


  261. ARMSTRONG P, Kuo YF, Cram P, Westra J, et al
    National trends in osteoporosis medication use among Medicare beneficiaries with and without Alzheimer's disease/related dementias.
    Osteoporos Int. 2023 Feb 2. doi: 10.1007/s00198-023-06680.
    PubMed     Abstract available


  262. MARINI F, Giusti F, Palmini G, Brandi ML, et al
    Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders.
    Osteoporos Int. 2023;34:213-238.
    PubMed     Abstract available


    January 2023
  263. MAFIRAKUREVA N, Paruk F, Cassim B, Lukhele M, et al
    The healthcare system costs of hip fracture care in South Africa.
    Osteoporos Int. 2023 Jan 27. doi: 10.1007/s00198-022-06664.
    PubMed     Abstract available


  264. VERDONCK C, Willems R, Borgermans L
    Implementation and operationalization of Integrated People-Centred Health Services delivery strategies in integrated osteoporosis care (IOC) initiatives: a systematic review.
    Osteoporos Int. 2023 Jan 25. doi: 10.1007/s00198-023-06678.
    PubMed     Abstract available


  265. KHAN MI
    Management of bone loss due to endocrine therapy during cancer treatment.
    Osteoporos Int. 2023 Jan 19. doi: 10.1007/s00198-023-06672.
    PubMed     Abstract available


  266. LOGGERS SAI, Geraerds AJLM, Joosse P, Willems HC, et al
    Correction to: Nonoperative versus operative management of frail institutionalized older patients with a proximal femoral fracture: a cost-utility analysis alongside a multicenter prospective cohort study.
    Osteoporos Int. 2023 Jan 17. doi: 10.1007/s00198-023-06673.
    PubMed    


  267. XIAO X, Wu Q
    The clinical utility of the BMD-related comprehensive genome-wide polygenic score in identifying individuals with a high risk of osteoporotic fractures.
    Osteoporos Int. 2023 Jan 9. doi: 10.1007/s00198-022-06654.
    PubMed     Abstract available


  268. LOGGERS SAI, Geraerds AJLM, Joosse P, Willems HC, et al
    Nonoperative versus operative management of frail institutionalized older patients with a proximal femoral fracture: a cost-utility analysis alongside a multicenter prospective cohort study.
    Osteoporos Int. 2023 Jan 7. doi: 10.1007/s00198-022-06638.
    PubMed     Abstract available


  269. TAN CW, Sahota O
    A 3-year retrospective analysis of patients admitted with clinical vertebral fragility fractures across hospitals in England, UK.
    Osteoporos Int. 2023 Jan 6. doi: 10.1007/s00198-022-06647.
    PubMed     Abstract available


  270. TUTAWORN T, Nieves JW, Wang Z, Levin JE, et al
    Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study.
    Osteoporos Int. 2023 Jan 5:1-12. doi: 10.1007/s00198-022-06648.
    PubMed     Abstract available


  271. CHARLES A, Iconaru L, Baleanu F, Benoit F, et al
    Are there specific clinical risk factors for the occurrence of multiple fractures? The FRISBEE study.
    Osteoporos Int. 2023 Jan 4. doi: 10.1007/s00198-022-06663.
    PubMed     Abstract available


  272. AUAIS M, Angermann H, Grubb M, Thomas C, et al
    The effectiveness and cost-effectiveness of clinical fracture-risk assessment tools in reducing future osteoporotic fractures among older adults: a structured scoping review.
    Osteoporos Int. 2023 Jan 4. doi: 10.1007/s00198-022-06659.
    PubMed     Abstract available


  273. CHANG E, Binkley N, Krueger D, Illgen R, et al
    Proposed bone health screening protocol to identify total knee arthroplasty patients for preoperative DXA.
    Osteoporos Int. 2023;34:171-177.
    PubMed     Abstract available


  274. GRAUMAM RQ, Pinheiro MM, Szejnfeld VL, Nery LE, et al
    High rate of abdominal aortic calcification in COPD patients and its relationship with musculoskeletal fragility.
    Osteoporos Int. 2023;34:69-79.
    PubMed     Abstract available


    December 2022
  275. ALVAREZ-NEBREDA ML, Weaver MJ, Uribe-Leitz T, Heng M, et al
    Epidemiology of pelvic and acetabular fractures in the USA from 2007 to 2014.
    Osteoporos Int. 2022 Dec 29. doi: 10.1007/s00198-022-06636.
    PubMed     Abstract available


  276. TENG PF, Chiang JM, Schafer AL, Sukerkar PA, et al
    Prevalence of osteoporosis in older male veterans receiving hip-containing computed tomography scans: opportunistic use of biomechanical computed tomography analysis (BCT).
    Osteoporos Int. 2022 Dec 29. doi: 10.1007/s00198-022-06624.
    PubMed     Abstract available


  277. NEWSON L, Ball S, Lewis R
    Letter to Editor: Our concerns about HRT not having a priority as a treatment for osteoporosis in the NOGG guidelines.
    Osteoporos Int. 2022 Dec 28. doi: 10.1007/s00198-022-06619.
    PubMed    


  278. GIRARD D, Wagner PP, Whittier DE, Boyd SK, et al
    C-reactive protein predicts endocortical expansion but not fracture in older men: the prospective STRAMBO study.
    Osteoporos Int. 2022 Dec 26. doi: 10.1007/s00198-022-06652.
    PubMed     Abstract available


  279. KANIS JA, Johansson H, Harvey NC, Lorentzon M, et al
    Adjusting conventional FRAX estimates of fracture probability according to the number of prior falls in the preceding year.
    Osteoporos Int. 2022 Dec 23. doi: 10.1007/s00198-022-06633.
    PubMed     Abstract available


  280. YANG Q, Cai G, Liu J, Wang X, et al
    Efficacy of cast immobilization versus surgical treatment for distal radius fractures in adults: a systematic review and meta-analysis.
    Osteoporos Int. 2022 Dec 20. doi: 10.1007/s00198-022-06649.
    PubMed     Abstract available


  281. KOSTEV K, Tanislav C
    Impact of the COVID-19 pandemic on osteoporotic hip fractures among outpatients in Germany.
    Osteoporos Int. 2022 Dec 17:1-2. doi: 10.1007/s00198-022-06641.
    PubMed    


  282. YU G, Tong S, Liu J, Wan Y, et al
    A systematic review of cost‑effectiveness analyses of sequential treatment for osteoporosis.
    Osteoporos Int. 2022 Dec 17. doi: 10.1007/s00198-022-06626.
    PubMed     Abstract available


  283. KANIS JA, Harvey NC, Liu E, Vandenput L, et al
    Primary hyperparathyroidism and fracture probability.
    Osteoporos Int. 2022 Dec 16. doi: 10.1007/s00198-022-06629.
    PubMed     Abstract available


  284. SCHLAUCH AM, Michelson JD, Holleran A, Ames E, et al
    The high-risk hip fracture patient and the palliative care consult : A retrospective study to investigate risks of complications and the utility of a palliative care consult in hip fracture patients undergoing surgical fixation.
    Osteoporos Int. 2022 Dec 14. doi: 10.1007/s00198-022-06634.
    PubMed     Abstract available


  285. YE C, Leslie WD
    Fracture risk and assessment in adults with cancer.
    Osteoporos Int. 2022 Dec 13. doi: 10.1007/s00198-022-06631.
    PubMed     Abstract available


  286. MAI H, Mc Evoy L, Wilson C, Marov L, et al
    Frailty and risk of subsequent fracture among older adults presenting to hospital with a minimal trauma fracture.
    Osteoporos Int. 2022 Dec 6. doi: 10.1007/s00198-022-06630.
    PubMed     Abstract available


  287. KARA M, Ozcakar L
    Sarcopenia, osteoporosis, and fractures: what we see mainly depends on how we look?
    Osteoporos Int. 2022 Dec 5. doi: 10.1007/s00198-022-06418.
    PubMed    


  288. HARRIS RJ, Parimi N, Cawthon PM, Strotmeyer ES, et al
    Response letter to "sarcopenia, osteoporosis and fractures: what we see".
    Osteoporos Int. 2022 Dec 5. doi: 10.1007/s00198-022-06620.
    PubMed    


  289. AGARWAL AR, Cohen JS, Jorgensen A, Thakkar SC, et al
    Trends in anti-osteoporotic medication utilization following fragility fracture in the USA from 2011 to 2019.
    Osteoporos Int. 2022 Dec 3. doi: 10.1007/s00198-022-06622.
    PubMed     Abstract available


  290. LANGDAHL B, Hofbauer LC, Ferrari S, Wang Z, et al
    Romosozumab efficacy and safety in European patients enrolled in the FRAME trial.
    Osteoporos Int. 2022;33:2527-2536.
    PubMed     Abstract available


  291. SADHUKHAN S, Mehta P, Rajender S, Gupta SK, et al
    Proposing a clinical algorithm for better diagnosis of hypophosphatasia in resource-limiting situations.
    Osteoporos Int. 2022;33:2479-2493.
    PubMed     Abstract available


    November 2022
  292. HASSANABADI N, Berger C, Papaioannou A, Cheung AM, et al
    Variation in bone mineral density and fractures over 20 years among Canadians: a comparison of the Canadian Multicenter Osteoporosis Study and the Canadian Longitudinal Study on Aging.
    Osteoporos Int. 2022 Nov 30. doi: 10.1007/s00198-022-06623.
    PubMed     Abstract available


  293. SUMREIN BO, Berg HE, Launonen AP, Landell P, et al
    Mortality following proximal humerus fracture-a nationwide register study of 147,692 fracture patients in Sweden.
    Osteoporos Int. 2022 Nov 26. doi: 10.1007/s00198-022-06612.
    PubMed     Abstract available


  294. TARANTINO U, Greggi C, Visconti VV, Cariati I, et al
    Fracture liaison service model: project design and accreditation.
    Osteoporos Int. 2022 Nov 24. doi: 10.1007/s00198-022-06600.
    PubMed     Abstract available


  295. NG E, Ashkar C, Seeman E, Schneider HG, et al
    A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients.
    Osteoporos Int. 2022 Nov 24. doi: 10.1007/s00198-022-06597.
    PubMed     Abstract available


  296. MATTHEWS MJ, Troy KL, Battaglino RA, Nguyen N, et al
    Comparison of DXA-based versus CT-based indices to predict prevalent fracture history in men with spinal cord injury.
    Osteoporos Int. 2022 Nov 23. doi: 10.1007/s00198-022-06575.
    PubMed     Abstract available


  297. NURMI-LUTHJE I, Tiihonen R, Paattiniemi EL, Sarkkinen H, et al
    Author response to the comments on our article Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up.
    Osteoporos Int. 2022 Nov 21. doi: 10.1007/s00198-022-06607.
    PubMed    


  298. LI C, Lu K
    Comments on "Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up".
    Osteoporos Int. 2022 Nov 21. doi: 10.1007/s00198-022-06417.
    PubMed    


  299. DING BTK, Lim HF, Johari F, Kunnasegaran R, et al
    An Orthopaedic Surgeon Led Osteoporosis (OSLO) Model of Care reduces early recurrent fracture rates and improves treatment compliance in patients treated for osteoporotic fractures.
    Osteoporos Int. 2022 Nov 21. doi: 10.1007/s00198-022-06595.
    PubMed     Abstract available


  300. PERIS P, Monegal A, Makitie RE, Guanabens N, et al
    Osteoporosis related to WNT1 variants: a not infrequent cause of osteoporosis.
    Osteoporos Int. 2022 Nov 18. pii: 10.1007/s00198-022-06609.
    PubMed     Abstract available


  301. BINKLEY N, Schousboe JT, Lix LM, Morin SN, et al
    Should vertebral fracture assessment be performed in Fracture Liaison Service patients with non-vertebral fracture?
    Osteoporos Int. 2022 Nov 16. pii: 10.1007/s00198-022-06586.
    PubMed     Abstract available


  302. GAO SS, Zhao Y
    The effects of beta-carotene on osteoporosis: a systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2022 Nov 16. pii: 10.1007/s00198-022-06593.
    PubMed     Abstract available


  303. JACOBSON BENSKY M, Adler L, Banon T, Gabay L, et al
    Risk of major osteoporotic fractures among ultra-orthodox Jews.
    Osteoporos Int. 2022 Nov 11. pii: 10.1007/s00198-022-06522.
    PubMed     Abstract available


  304. HOFFMANN I, Kohl M, von Stengel S, Jakob F, et al
    Exercise and the prevention of major osteoporotic fractures in adults: a systematic review and meta-analysis with special emphasis on intensity progression and study duration.
    Osteoporos Int. 2022 Nov 10. pii: 10.1007/s00198-022-06592.
    PubMed     Abstract available


  305. SHEETS KM, Buzkova P, Chen Z, Carbone LD, et al
    Association of covert brain infarcts and white matter hyperintensities with risk of hip fracture in older adults: the Cardiovascular Health Study.
    Osteoporos Int. 2022 Nov 10. pii: 10.1007/s00198-022-06565.
    PubMed     Abstract available


  306. PHUNG K, McAdam L, Ma J, McMillan HJ, et al
    Risk factors associated with prevalent vertebral fractures in Duchenne muscular dystrophy.
    Osteoporos Int. 2022 Nov 7. pii: 10.1007/s00198-022-06578.
    PubMed     Abstract available


  307. DWIVEDI R, Mishra L, Ghobrial H, Abbas H, et al
    Prevalent vertebral fractures in patients admitted with acute hip fracture.
    Osteoporos Int. 2022 Nov 7. pii: 10.1007/s00198-022-06564.
    PubMed    


  308. AALTONEN HL, O'Reilly MK, Linnau KF, Dong Q, et al
    m2ABQ-a proposed refinement of the modified algorithm-based qualitative classification of osteoporotic vertebral fractures.
    Osteoporos Int. 2022 Nov 7. pii: 10.1007/s00198-022-06546.
    PubMed     Abstract available


  309. SALE JEM, Yang A, Inrig T, Gandhi S, et al
    Patients not taking a previously prescribed bone active medication now prescribed medication through Ontario FLS.
    Osteoporos Int. 2022;33:2435-2440.
    PubMed     Abstract available


    October 2022
  310. KANIS JA, McCloskey EV, Harvey NC, Cooper C, et al
    The need to distinguish intervention thresholds and diagnostic thresholds in the management of osteoporosis.
    Osteoporos Int. 2022 Oct 25. pii: 10.1007/s00198-022-06567.
    PubMed     Abstract available


  311. POORIRANI S, Taheri SL, Mostafavi SA
    Scaffolds: a biomaterial engineering in targeted drug delivery for osteoporosis.
    Osteoporos Int. 2022 Oct 15. pii: 10.1007/s00198-022-06543.
    PubMed     Abstract available


  312. MORI S, Hagino H, Sugimoto T, Tanaka S, et al
    Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05.
    Osteoporos Int. 2022 Oct 14. pii: 10.1007/s00198-022-06570.
    PubMed     Abstract available


  313. HUANG YP, Chen LS, Feng SH, Liang YS, et al
    Tea consumption and the risks of osteoporosis and hip fracture: a population-based longitudinal follow-up study.
    Osteoporos Int. 2022 Oct 14. pii: 10.1007/s00198-022-06569.
    PubMed     Abstract available


  314. KOO HY, Cho EB, Kong SH, Han K, et al
    Fracture risk in Parkinson's disease according to its severity and duration.
    Osteoporos Int. 2022 Oct 7. pii: 10.1007/s00198-022-06562.
    PubMed     Abstract available


  315. WONG BLL, Chan YH, O'Neill GK, Murphy D, et al
    Frailty, length of stay and cost in hip fracture patients.
    Osteoporos Int. 2022 Oct 5. pii: 10.1007/s00198-022-06553.
    PubMed     Abstract available


    September 2022
  316. KANIS JA, Johansson H, Harvey NC, Gudnason V, et al
    Adjusting conventional FRAX estimates of fracture probability according to the number of prior fractures.
    Osteoporos Int. 2022 Sep 26. pii: 10.1007/s00198-022-06550.
    PubMed     Abstract available


  317. SHABANI F, Tsinaslanidis G, Thimmaiah R, Khattak M, et al
    Correction to: Effect of institution volume on mortality and outcomes in osteoporotic hip fracture care.
    Osteoporos Int. 2022 Sep 23. pii: 10.1007/s00198-022-06440.
    PubMed    


    August 2022
  318. MORIN SN, Berger C, Papaioannou A, Cheung AM, et al
    Race/ethnic differences in the prevalence of osteoporosis, falls and fractures: a cross-sectional analysis of the Canadian Longitudinal Study on Aging.
    Osteoporos Int. 2022 Aug 31. pii: 10.1007/s00198-022-06539.
    PubMed     Abstract available


  319. YE C, Leslie WD, Al-Azazi S, Yan L, et al
    Fractures and long-term mortality in cancer patients: a population-based cohort study.
    Osteoporos Int. 2022 Aug 29. pii: 10.1007/s00198-022-06542.
    PubMed     Abstract available


  320. DANG T, Faje AT, Meenaghan E, Bredella MA, et al
    Bone marrow adipose tissue is associated with fracture history in anorexia nervosa.
    Osteoporos Int. 2022 Aug 23. pii: 10.1007/s00198-022-06527.
    PubMed     Abstract available


  321. BOKRANTZ T, Manhem K, Lorentzon M, Karlsson M, et al
    The association between peripheral arterial disease and risk for hip fractures in elderly men is not explained by low hip bone mineral density. Results from the MrOS Sweden study.
    Osteoporos Int. 2022 Aug 19. pii: 10.1007/s00198-022-06535.
    PubMed     Abstract available


  322. HAWLEY S, Dela S, Burton A, Paruk F, et al
    Incidence and number of fragility fractures of the hip in South Africa: estimated projections from 2020 to 2050.
    Osteoporos Int. 2022 Aug 13. pii: 10.1007/s00198-022-06525.
    PubMed     Abstract available


  323. DRUMMOND K, Bennett R, Gibbs J, Wei R, et al
    Perceptions of fracture and fall risk and of the benefits and barriers to exercise in adults with diabetes.
    Osteoporos Int. 2022 Aug 8. pii: 10.1007/s00198-022-06524.
    PubMed     Abstract available


  324. YANG J, Liao M, Wang Y, Chen L, et al
    Opportunistic osteoporosis screening using chest CT with artificial intelligence.
    Osteoporos Int. 2022 Aug 6. pii: 10.1007/s00198-022-06491.
    PubMed     Abstract available


  325. SOGAARD AJ, Aga R, Holvik K, Meyer HE, et al
    Characteristics of fallers who later sustain a hip fracture: a NOREPOS study.
    Osteoporos Int. 2022 Aug 4. pii: 10.1007/s00198-022-06490.
    PubMed     Abstract available


  326. SHIN JW, He Q, Suk YJ, Kim SH, et al
    Comparison of the efficacy between sequential therapy with teriparatide and denosumab and denosumab monotherapy in suppressing fragility fracture risk.
    Osteoporos Int. 2022 Aug 4. pii: 10.1007/s00198-022-06495.
    PubMed     Abstract available


  327. KIM MJ, Jillian H, Rachael T, Debra W, et al
    Is repeated childhood fracture related to areal bone density or body composition in middle age?
    Osteoporos Int. 2022 Aug 2. pii: 10.1007/s00198-022-06500.
    PubMed     Abstract available


  328. LIPPUNER K, Rimmer G, Stuck AK, Schwab P, et al
    Hospitalizations for major osteoporotic fractures in Switzerland: a long-term trend analysis between 1998 and 2018.
    Osteoporos Int. 2022 Aug 2. pii: 10.1007/s00198-022-06481.
    PubMed     Abstract available


  329. COSMAN F, Cooper C, Wang Y, Mitlak B, et al
    Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claims database study.
    Osteoporos Int. 2022;33:1703-1714.
    PubMed     Abstract available


    July 2022
  330. TARANTINO U, Cariati I, Greggi C, Iundusi R, et al
    Gaps and alternative surgical and non-surgical approaches in the bone fragility management: an updated review.
    Osteoporos Int. 2022 Jul 18. pii: 10.1007/s00198-022-06482.
    PubMed     Abstract available


  331. BARUTH JM, Lapid MI, Clarke B, Shin AY, et al
    Distal radius fractures and risk of incident neurocognitive disorders in older adults: a retrospective cohort study.
    Osteoporos Int. 2022 Jul 15. pii: 10.1007/s00198-022-06497.
    PubMed     Abstract available


  332. LORENTZON M, Johansson H, Harvey NC, Liu E, et al
    Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability-results from the Women's Health Initiative hormone therapy trials.
    Osteoporos Int. 2022 Jul 14. pii: 10.1007/s00198-022-06483.
    PubMed     Abstract available


  333. OSTOVAR A, Mousavi A, Sajjadi-Jazi SM, Rajabi M, et al
    The economic burden of osteoporosis in Iran in 2020.
    Osteoporos Int. 2022 Jul 11. pii: 10.1007/s00198-022-06484.
    PubMed     Abstract available


  334. ANUSITVIWAT C, Vanitcharoenkul E, Chotiyarnwong P, Unnanuntana A, et al
    Surgical treatment for fragility hip fractures during the COVID-19 pandemic resulted in lower short-term postoperative functional outcome and a higher complication rate compared to the pre-pandemic period.
    Osteoporos Int. 2022 Jul 9. pii: 10.1007/s00198-022-06485.
    PubMed     Abstract available


  335. FUJIWARA S, Buchanan-Hughes A, Ng A, Page J, et al
    Real-world evaluation of osteoporotic fractures using the Japan Medical Data Vision database.
    Osteoporos Int. 2022 Jul 2. pii: 10.1007/s00198-022-06472.
    PubMed     Abstract available


  336. HA J, Kim J, Jeong C, Lim Y, et al
    Effect of follow-up raloxifene therapy after denosumab discontinuation in postmenopausal women.
    Osteoporos Int. 2022;33:1591-1599.
    PubMed     Abstract available


  337. WONG RMY, Wong PY, Liu C, Wong HW, et al
    The imminent risk of a fracture-existing worldwide data: a systematic review and meta-analysis.
    Osteoporos Int. 2022 Jul 1. pii: 10.1007/s00198-022-06473.
    PubMed     Abstract available


    June 2022
  338. TRAN O, Silverman S, Xu X, Bonafede M, et al
    Correction to: Long-term direct and indirect economic burden associated with osteoporotic fracture in US postmenopausal women.
    Osteoporos Int. 2022 Jun 29. pii: 10.1007/s00198-022-06410.
    PubMed    


  339. PAN B, Cai J, Zhao P, Liu J, et al
    Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Osteoporos Int. 2022 Jun 28. pii: 10.1007/s00198-022-06459.
    PubMed     Abstract available


  340. WONG RMY, Ng RWK, Chau WW, Liu WH, et al
    Montreal cognitive assessment (MoCA) is highly correlated with 1-year mortality in hip fracture patients.
    Osteoporos Int. 2022 Jun 28. pii: 10.1007/s00198-022-06426.
    PubMed     Abstract available


  341. LAI SW
    Gamma-glutamyl-transferase and hip fracture.
    Osteoporos Int. 2022 Jun 28. pii: 10.1007/s00198-022-06452.
    PubMed    


  342. BROZEK W, Ulmer H, Pompella A, Nagel G, et al
    Response to comments on "Gamma-glutamyl-transferase is associated with incident hip fractures in women and men >/= 50 years: a large population-based cohort study".
    Osteoporos Int. 2022 Jun 28. pii: 10.1007/s00198-022-06442.
    PubMed    


  343. MCCLOSKEY EV, Chotiyarnwong P, Harvey NC, Lorentzon M, et al
    Population screening for fracture risk in postmenopausal women - a logical step in reducing the osteoporotic fracture burden?
    Osteoporos Int. 2022 Jun 28. pii: 10.1007/s00198-022-06419.
    PubMed    


  344. ABDALBARY M, Sobh M, Elnagar S, Elhadedy MA, et al
    Management of osteoporosis in patients with chronic kidney disease.
    Osteoporos Int. 2022 Jun 24. pii: 10.1007/s00198-022-06462.
    PubMed     Abstract available


  345. ZHAO C, Liu X, Wang Y, Guo J, et al
    Correction: The effects of biomechanical factors on adjacent vertebral compression fractures after percutaneous kyphoplasty: a propensity score matching analysis.
    Osteoporos Int. 2022 Jun 17. pii: 10.1007/s00198-022-06441.
    PubMed    


  346. TALEVSKI J, Sanders KM, Lal A, Watts JJ, et al
    A micro-costing analysis of post-fracture care pathways: results from the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS).
    Osteoporos Int. 2022 Jun 15. pii: 10.1007/s00198-022-06460.
    PubMed     Abstract available


  347. BAILEY S, Mhango G, Lin JJ
    The impact of bone mineral density screening on incident fractures and healthcare resource utilization among postmenopausal breast cancer survivors treated with aromatase inhibitors.
    Osteoporos Int. 2022 Jun 14. pii: 10.1007/s00198-022-06458.
    PubMed     Abstract available


  348. LEE JM, Park CH, Yoo JI, Kim JT, et al
    Atypical periprosthetic femoral fracture with stem breakage: a case report.
    Osteoporos Int. 2022 Jun 10. pii: 10.1007/s00198-022-06463.
    PubMed     Abstract available


  349. ROSS BJ, Ross AJ, Lee OC, Waters TL, et al
    Osteoporosis management and secondary fragility fracture rates in patients with multiple sclerosis: a matched cohort study.
    Osteoporos Int. 2022 Jun 7. pii: 10.1007/s00198-022-06451.
    PubMed     Abstract available


  350. SHI W, Huang C, Chen S, Yang C, et al
    Long-term exposure to air pollution increases hip fracture incidence rate and related mortality: analysis of National Hip Fracture Database.
    Osteoporos Int. 2022 Jun 3. pii: 10.1007/s00198-022-06445.
    PubMed     Abstract available


  351. GOLD LS, Cody RF Jr, Tan WK, Marcum ZA, et al
    Osteoporosis identification among previously undiagnosed individuals with vertebral fractures.
    Osteoporos Int. 2022 Jun 3. pii: 10.1007/s00198-022-06450.
    PubMed     Abstract available


  352. SHIEH A, Greendale GA, Cauley JA, Karvonen-Gutierriez C, et al
    Prediabetes and insulin resistance are associated with lower trabecular bone score (TBS): cross-sectional results from the Study of Women's Health Across the Nation TBS Study.
    Osteoporos Int. 2022;33:1365-1372.
    PubMed     Abstract available


    May 2022
  353. VANDENPUT L, Johansson H, McCloskey EV, Liu E, et al
    Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan.
    Osteoporos Int. 2022 May 31. pii: 10.1007/s00198-022-06435.
    PubMed     Abstract available


  354. SAHOTA A, Barbary R, Cameron M, Stewart AM, et al
    Safety of zoledronate in older patients at high risk of fracture with reduced renal function.
    Osteoporos Int. 2022 May 23. pii: 10.1007/s00198-022-06427.
    PubMed    


  355. ZHAO C, Liu X, Wang Y, Guo J, et al
    The effects of biomechanical factors on adjacent vertebral compression fractures after percutaneous kyphoplasty: a propensity score matching analysis.
    Osteoporos Int. 2022 May 18. pii: 10.1007/s00198-022-06428.
    PubMed     Abstract available


  356. KONG XK, Zhao ZY, Zhang D, Xie R, et al
    Major osteoporosis fracture prediction in type 2 diabetes: a derivation and comparison study.
    Osteoporos Int. 2022 May 18. pii: 10.1007/s00198-022-06425.
    PubMed     Abstract available


  357. KONSTANTELOS N, Rzepka AM, Burden AM, Cheung AM, et al
    Fracture definitions in observational osteoporosis drug effects studies that leverage healthcare administrative (claims) data: a scoping review.
    Osteoporos Int. 2022 May 17. pii: 10.1007/s00198-022-06395.
    PubMed     Abstract available


  358. LI J, Li D, Wang X, Zhang L, et al
    The impact of body mass index on mortality rates of hip fracture patients: a systematic review and meta-analysis.
    Osteoporos Int. 2022 May 13. pii: 10.1007/s00198-022-06415.
    PubMed     Abstract available


  359. HAYDEN AC, Binkley N, Krueger D, Bernatz JT, et al
    Effect of degeneration on bone mineral density, trabecular bone score and CT Hounsfield unit measurements in a spine surgery patient population.
    Osteoporos Int. 2022 May 12. pii: 10.1007/s00198-022-06407.
    PubMed     Abstract available


  360. SUJIC R, Yang A, Ansari H, Bogoch ER, et al
    Fragility fracture patients with a history of prior fractures more likely to present with multiple risk factors: findings from a province-wide fracture liaison service.
    Osteoporos Int. 2022 May 10. pii: 10.1007/s00198-022-06384.
    PubMed     Abstract available


  361. SHABANI F, Tsinaslanidis G, Thimmaiah R, Khatak M, et al
    Correction to: Effect of institution volume on mortality and outcomes in osteoporotic hip fracture care.
    Osteoporos Int. 2022 May 3. pii: 10.1007/s00198-022-06323.
    PubMed    


  362. ANABTAWI A, Holyoak M, He J, Cristiano E, et al
    Trabecular bone score in people with cystic fibrosis.
    Osteoporos Int. 2022;33:1137-1145.
    PubMed     Abstract available


    April 2022
  363. LEBOFF MS, Greenspan SL, Insogna KL, Lewiecki EM, et al
    The clinician's guide to prevention and treatment of osteoporosis.
    Osteoporos Int. 2022 Apr 28. pii: 10.1007/s00198-021-05900.
    PubMed     Abstract available


  364. JOHANSSON L, Johansson H, Axelsson KF, Litsne H, et al
    Improved fracture risk prediction by adding VFA-identified vertebral fracture data to BMD by DXA and clinical risk factors used in FRAX.
    Osteoporos Int. 2022 Apr 22. pii: 10.1007/s00198-022-06387.
    PubMed     Abstract available


  365. LEE SW, Han K, Kwon HS
    Weight change and the risk of hip fractures in patients with type 2 diabetes: a nationwide cohort study.
    Osteoporos Int. 2022 Apr 19. pii: 10.1007/s00198-022-06398.
    PubMed     Abstract available


  366. ZENG X, Su Y, Tan A, Zou L, et al
    The association of coffee consumption with the risk of osteoporosis and fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2022 Apr 15. pii: 10.1007/s00198-022-06399.
    PubMed     Abstract available


  367. LOGGERS SAI, Nijdam TMP, Folbert EC, Hegeman JHH, et al
    Prognosis and institutionalization of frail community-dwelling older patients following a proximal femoral fracture: a multicenter retrospective cohort study.
    Osteoporos Int. 2022 Apr 9. pii: 10.1007/s00198-022-06394.
    PubMed     Abstract available


  368. XU W, Wu W, Yang S, Chen T, et al
    Correction to: Risk of osteoporosis and fracture after hysterectomies without oophorectomies: a systematic review and pooled analysis.
    Osteoporos Int. 2022 Apr 6. pii: 10.1007/s00198-022-06397.
    PubMed    


  369. HARRIS RJ, Parimi N, Cawthon PM, Strotmeyer ES, et al
    Associations of components of sarcopenia with risk of fracture in the Osteoporotic Fractures in Men (MrOS) study.
    Osteoporos Int. 2022 Apr 5. pii: 10.1007/s00198-022-06390.
    PubMed     Abstract available


  370. DU EZ, Wang YXJ
    CT detects more osteoporotic endplate depressions than radiograph: a descriptive comparison of 76 vertebrae.
    Osteoporos Int. 2022 Apr 4. pii: 10.1007/s00198-022-06391.
    PubMed     Abstract available


    March 2022
  371. GONZALEZ-QUEVEDO D, Perez-Del-Rio V, Moriel-Garceso D, Fernandez-Arroyabe N, et al
    A 2-year follow-up of a novel Fracture Liaison Service: can we reduce the mortality in elderly hip fracture patients? A prospective cohort study.
    Osteoporos Int. 2022 Mar 31. pii: 10.1007/s00198-022-06298.
    PubMed     Abstract available


  372. LENTLE BC, Prior JC
    Osteoporotic vertebral fracture (OVF): diagnosis requires an informed observer.
    Osteoporos Int. 2022 Mar 30. pii: 10.1007/s00198-021-06287.
    PubMed    


  373. WANG YXJ
    Osteoporotic vertebral endplate and/or cortex fracture is not always radiographically detectable.
    Osteoporos Int. 2022 Mar 30. pii: 10.1007/s00198-021-06254.
    PubMed    


  374. XU WX, Wu W, Yang S, Chen T, et al
    Risk of osteoporosis and fracture after hysterectomies without oophorectomies: a systematic review and pooled analysis.
    Osteoporos Int. 2022 Mar 29. pii: 10.1007/s00198-022-06383.
    PubMed     Abstract available


  375. AKESSON KE, Ganda K, Deignan C, Oates MK, et al
    Post-fracture care programs for prevention of subsequent fragility fractures: a literature assessment of current trends.
    Osteoporos Int. 2022 Mar 24. pii: 10.1007/s00198-022-06358.
    PubMed     Abstract available


  376. DEY M, Bukhari M
    Cluster analysis demonstrates co-existing sites of fragility fracture and associated comorbidities.
    Osteoporos Int. 2022 Mar 21. pii: 10.1007/s00198-022-06377.
    PubMed     Abstract available


  377. SCHOEB M, Winter EM, Malgo F, Schipper IB, et al
    Bone material strength index as measured by in vivo impact microindentation is normal in subjects with high-energy trauma fractures.
    Osteoporos Int. 2022 Mar 21. pii: 10.1007/s00198-022-06368.
    PubMed     Abstract available


  378. JAVAID MK, Harvey NC, McCloskey EV, Kanis JA, et al
    Assessment and management of imminent fracture risk in the setting of the fracture liaison service.
    Osteoporos Int. 2022 Mar 14. pii: 10.1007/s00198-021-06284.
    PubMed    


  379. HA J, Baek KH
    Correction to: Response to letter, re. "Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data".
    Osteoporos Int. 2022 Mar 11. pii: 10.1007/s00198-022-06373.
    PubMed    


  380. ARAIZA-NAVA B, Mendez-Sanchez L, Clark P, Peralta-Pedrero ML, et al
    Short- and long-term prognostic factors associated with functional recovery in elderly patients with hip fracture: A systematic review.
    Osteoporos Int. 2022 Mar 5. pii: 10.1007/s00198-022-06346.
    PubMed     Abstract available


    February 2022
  381. OKUDA R, Osaki M, Saeki Y, Okano T, et al
    Effect of coordinator-based osteoporosis intervention on quality of life in patients with fragility fractures: a prospective randomized trial.
    Osteoporos Int. 2022 Feb 23. pii: 10.1007/s00198-021-06279.
    PubMed     Abstract available


  382. BASTOUNIS A, Langley T, Davis S, Paskins Z, et al
    Comparing medication adherence in patients receiving bisphosphonates for preventing fragility fractures: a comprehensive systematic review and network meta-analysis.
    Osteoporos Int. 2022 Feb 21. pii: 10.1007/s00198-022-06350.
    PubMed     Abstract available


  383. KWAK MJ, Digbeu BD, des Bordes J, Rianon N, et al
    The association of frailty with clinical and economic outcomes among hospitalized older adults with hip fracture surgery.
    Osteoporos Int. 2022 Feb 18. pii: 10.1007/s00198-021-06215.
    PubMed     Abstract available


  384. LESLIE WD, Moller S, Skjodt MK, Yan L, et al
    FREM predicts 10-year incident fracture risk independent of FRAX(R) probability: a registry-based cohort study.
    Osteoporos Int. 2022 Feb 17. pii: 10.1007/s00198-022-06349.
    PubMed     Abstract available


  385. LAI SW
    Diabetes mellitus and hip fracture.
    Osteoporos Int. 2022 Feb 17. pii: 10.1007/s00198-022-06309.
    PubMed    


  386. JEONGHOON H, Ki-Hyun B
    Response to letter, re. "Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data".
    Osteoporos Int. 2022 Feb 17. pii: 10.1007/s00198-022-06336.
    PubMed    


  387. LEMS WF, van den Bergh JP, Geusens PPMM
    The fracture liaison service, a step forward not only in fracture reduction, but also in mortality reduction.
    Osteoporos Int. 2022 Feb 15. pii: 10.1007/s00198-022-06335.
    PubMed    


  388. HWANG D, Kim CH, Lee Y, Kim JW, et al
    Association of atypical femoral fracture location and lower limb mechanical axis: a computed tomography-based finite element analysis.
    Osteoporos Int. 2022 Feb 3. pii: 10.1007/s00198-021-06173.
    PubMed     Abstract available


  389. FLEHR A, Kallgard J, Alven J, Lagerstrand K, et al
    Development of a novel method to measure bone marrow fat fraction in older women using high-resolution peripheral quantitative computed tomography.
    Osteoporos Int. 2022 Feb 3. pii: 10.1007/s00198-021-06224.
    PubMed     Abstract available


    January 2022
  390. ASAHI R, Nakamura Y, Kanai M, Watanabe K, et al
    Association with sagittal alignment and osteoporosis-related fractures in outpatient women with osteoporosis.
    Osteoporos Int. 2022 Jan 29. pii: 10.1007/s00198-021-06282.
    PubMed     Abstract available


  391. AXELSSON KF, Woessner MN, Litsne H, Wheeler M, et al
    Eating disorders are associated with increased risk of fall injury and fracture in Swedish men and women.
    Osteoporos Int. 2022 Jan 27. pii: 10.1007/s00198-022-06312.
    PubMed     Abstract available


  392. BEAUDART C, Boonen A, Li N, Bours S, et al
    Patient preferences for lifestyle behaviours in osteoporotic fracture prevention: a cross-European discrete choice experiment.
    Osteoporos Int. 2022 Jan 26. pii: 10.1007/s00198-022-06310.
    PubMed     Abstract available


  393. GUPTA A, Cha T, Schwab J, Fogel H, et al
    Response to Assessing impacts of gender on adverse postoperative outcomes in patients undergoing osteoporotic vertebral compression fracture surgery.
    Osteoporos Int. 2022 Jan 21. pii: 10.1007/s00198-021-06243.
    PubMed    


  394. HONG FX, Xue FS, Hu B, Tian T, et al
    Assessing impacts of gender on adverse postoperative outcomes in patients undergoing osteoporotic vertebral compression fracture surgery.
    Osteoporos Int. 2022 Jan 21. pii: 10.1007/s00198-021-05992.
    PubMed    


  395. YE C, Schousboe JT, Morin SN, Lix LM, et al
    Time since prior fracture affects mortality at the time of clinical assessment: a registry-based cohort study.
    Osteoporos Int. 2022 Jan 21. pii: 10.1007/s00198-021-06236.
    PubMed     Abstract available


  396. WAN Y, Zeng F, Tan H, Lu Y, et al
    Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review.
    Osteoporos Int. 2022 Jan 21. pii: 10.1007/s00198-021-06268.
    PubMed     Abstract available


  397. PINTO D, Alshahrani M, Chapurlat R, Chevalley T, et al
    The global approach to rehabilitation following an osteoporotic fragility fracture: A review of the rehabilitation working group of the International Osteoporosis Foundation (IOF) committee of scientific advisors.
    Osteoporos Int. 2022 Jan 20. pii: 10.1007/s00198-021-06240.
    PubMed     Abstract available


  398. BROZEK W, Ulmer H, Pompella A, Nagel G, et al
    Gamma-glutamyl-transferase is associated with incident hip fractures in women and men >/= 50 years: a large population-based cohort study.
    Osteoporos Int. 2022 Jan 20. pii: 10.1007/s00198-022-06307.
    PubMed     Abstract available


  399. SCHOUSBOE JT, Binkley N, Leslie WD
    Accurate estimation of vertebral fracture prevalence on lateral spine imaging requires use of validated ascertainment methods.
    Osteoporos Int. 2022 Jan 16. pii: 10.1007/s00198-021-06275.
    PubMed    


  400. LAI EC, Lin TC, Lange JL, Chen L, et al
    Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study.
    Osteoporos Int. 2022 Jan 15. pii: 10.1007/s00198-021-06291.
    PubMed     Abstract available


  401. PATEL R, Shen J, Nichols JF, Schousboe JT, et al
    Trabecular bone score and its association with Cobb angle kyphosis in older men: a cross-sectional study for the Osteoporotic Fractures in Men (MrOS) Study.
    Osteoporos Int. 2022 Jan 15. pii: 10.1007/s00198-021-06267.
    PubMed     Abstract available


  402. KIMMEL DB, Vennin S, Desyatova A, Turner JA, et al
    Bone architecture, bone material properties, and bone turnover in non-osteoporotic post-menopausal women with fragility fracture.
    Osteoporos Int. 2022 Jan 15. pii: 10.1007/s00198-022-06308.
    PubMed     Abstract available


  403. STROM RONNQUIST S, Viberg B, Kristensen MT, Palm H, et al
    Frailty and osteoporosis in patients with hip fractures under the age of 60-a prospective cohort of 218 individuals.
    Osteoporos Int. 2022 Jan 14. pii: 10.1007/s00198-021-06281.
    PubMed     Abstract available


  404. IIDA H, Sakai Y, Seki T, Watanabe T, et al
    Bisphosphonate treatment is associated with decreased mortality rates in patients after osteoporotic vertebral fracture.
    Osteoporos Int. 2022 Jan 13. pii: 10.1007/s00198-021-06264.
    PubMed     Abstract available


  405. IKI M, Fujimori K, Nakatoh S, Tamaki J, et al
    Guideline adherence by physicians for management of glucocorticoid-induced osteoporosis in Japan: a nationwide health insurance claims database study.
    Osteoporos Int. 2022 Jan 13. pii: 10.1007/s00198-021-06265.
    PubMed     Abstract available


  406. BERNARDES M, Monteiro R, Martins MJ
    Mineral-rich water consumption as a non-pharmacological intervention for early menopausal bone mineral density preservation and reduction of long-term fracture risk: comment on Billington et al. Osteoporos Int. 2021;32(7):1313-20.
    Osteoporos Int. 2022 Jan 12. pii: 10.1007/s00198-021-06272.
    PubMed    


  407. FERRIS H, Brent L, Sorensen J
    Cost of hospitalisation for hip fracture-findings from the Irish hip fracture database.
    Osteoporos Int. 2022 Jan 11. pii: 10.1007/s00198-021-06294.
    PubMed     Abstract available


  408. SALE JEM, Frankel L, Yu W, Paiva J, et al
    Patients experience a need for informal care after a fragility fracture.
    Osteoporos Int. 2022 Jan 10. pii: 10.1007/s00198-021-06273.
    PubMed     Abstract available


  409. SHABANI F, Tsinaslanidis G, Thimmaiah R, Khatak M, et al
    Effect of institution volume on mortality and outcomes in osteoporotic hip fracture care.
    Osteoporos Int. 2022 Jan 8. pii: 10.1007/s00198-021-06249.
    PubMed     Abstract available


  410. CHEN YT, Kao ZK, Shih CJ, Ou SM, et al
    Magnesium exposure increases hip fracture risks in patients with chronic kidney disease: a population-based nested case-control study.
    Osteoporos Int. 2022 Jan 7. pii: 10.1007/s00198-022-06301.
    PubMed     Abstract available


  411. CHEN X, Zhang J, Lin Y, Liu Z, et al
    Risk factors for postoperative mortality at 30 days in elderly Chinese patients with hip fractures.
    Osteoporos Int. 2022 Jan 7. pii: 10.1007/s00198-021-06257.
    PubMed     Abstract available


  412. CLAUSEN A, Moller S, Skjodt MK, Bech BH, et al
    Evaluating the performance of the Charlson Comorbidity Index (CCI) in fracture risk prediction and developing a new Charlson Fracture Index (CFI): a register-based cohort study.
    Osteoporos Int. 2022 Jan 6. pii: 10.1007/s00198-021-06293.
    PubMed     Abstract available


  413. MILTO AJ, El Bitar Y, Scaife SL, Thuppal S, et al
    Differences in hospital length of stay and total hospital charge by income level in patients hospitalized for hip fractures.
    Osteoporos Int. 2022 Jan 6. pii: 10.1007/s00198-021-06260.
    PubMed     Abstract available


  414. SAAD RK, Ghezzawi M, Habli D, Alami RS, et al
    Fracture risk following bariatric surgery: a systematic review and meta-analysis.
    Osteoporos Int. 2022 Jan 5. pii: 10.1007/s00198-021-06206.
    PubMed     Abstract available


  415. BERMAN NK, Honig S, Cronstein BN, Pillinger MH, et al
    The effects of caffeine on bone mineral density and fracture risk.
    Osteoporos Int. 2022 Jan 4. pii: 10.1007/s00198-021-05972.
    PubMed     Abstract available


  416. DOCKERY F, Glynn A, Franks K, Carey JJ, et al
    Fracture liaison services in Ireland-how do we compare to international standards?
    Osteoporos Int. 2022 Jan 4. pii: 10.1007/s00198-021-06251.
    PubMed     Abstract available


  417. JOHANSSON H, Naureen G, Iqbal R, Jafri L, et al
    FRAX-based intervention thresholds for Pakistan.
    Osteoporos Int. 2022;33:105-112.
    PubMed     Abstract available


    December 2021
  418. NURMI-LUTHJE I, Tiihonen R, Paattiniemi EL, Sarkkinen H, et al
    Correction to: Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up.
    Osteoporos Int. 2021 Dec 3. pii: 10.1007/s00198-021-06222.
    PubMed    


  419. FREI AN, Gellad WF, Wertli MM, Haynes AG, et al
    Trends and regional variation in vertebroplasty and kyphoplasty in Switzerland: a population-based small area analysis.
    Osteoporos Int. 2021;32:2515-2524.
    PubMed     Abstract available


  420. BOCKER W, Doobaree IU, Khachatryan A, Dornstauder E, et al
    Correction to: Fractures in untreated patients with osteoporosis in Germany: an InGef healthcare insurance database analysis.
    Osteoporos Int. 2021 Dec 1. pii: 10.1007/s00198-021-06244.
    PubMed    


    November 2021
  421. AGARWAL A, Leslie WD, Nguyen TV, Morin SN, et al
    Predictive performance of the Garvan Fracture Risk Calculator: a registry-based cohort study.
    Osteoporos Int. 2021 Nov 28. pii: 10.1007/s00198-021-06252.
    PubMed     Abstract available


  422. AGARWAL G, Milan C, Mohsin Z, Mahoney S, et al
    Multiple myeloma screening within a fracture liaison service (FLS).
    Osteoporos Int. 2021 Nov 26. pii: 10.1007/s00198-021-06233.
    PubMed     Abstract available


  423. GLEICH J, Kussmaul AC, Steiner E, Bocker W, et al
    High prevalence of missed information related on bone health in orthogeriatric patients with fragility fractures of the pelvis-an institutional register-based analysis.
    Osteoporos Int. 2021 Nov 24. pii: 10.1007/s00198-021-06246.
    PubMed     Abstract available


  424. HORII C, Iidaka T, Muraki S, Oka H, et al
    The cumulative incidence of and risk factors for morphometric severe vertebral fractures in Japanese men and women: the ROAD study third and fourth surveys.
    Osteoporos Int. 2021 Nov 19. pii: 10.1007/s00198-021-06143.
    PubMed     Abstract available


  425. VAN DEN BERG P, Sluiter E, Oosterveld MH, van Leerdam M, et al
    Single pharmacy governed denosumab home administration: optimal adherence by means of a fracture liaison service (FLS) and home care collaboration.
    Osteoporos Int. 2021 Nov 13. pii: 10.1007/s00198-021-06234.
    PubMed     Abstract available


  426. BABATUNDE OO, Bucknall M, Burton C, Forsyth JJ, et al
    Long-term clinical and socio-economic outcomes following wrist fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2021 Nov 11. pii: 10.1007/s00198-021-06214.
    PubMed     Abstract available


  427. LIU Z, Zhang X, Liu H, Wang D, et al
    A nomogram for short-term recurrent pain after percutaneous vertebroplasty for osteoporotic vertebral compression fractures.
    Osteoporos Int. 2021 Nov 11. pii: 10.1007/s00198-021-06232.
    PubMed     Abstract available


  428. GOUBAR A, Ayis S, Beaupre L, Cameron ID, et al
    The impact of the frequency, duration and type of physiotherapy on discharge after hip fracture surgery: a secondary analysis of UK national linked audit data.
    Osteoporos Int. 2021 Nov 8. pii: 10.1007/s00198-021-06195.
    PubMed     Abstract available


  429. NI W, Ricker C, Quinn M, Gasquet N, et al
    Trends in opioid use following balloon kyphoplasty or vertebroplasty for the treatment of vertebral compression fractures.
    Osteoporos Int. 2021 Nov 2. pii: 10.1007/s00198-021-06163.
    PubMed     Abstract available


  430. SHAH A, Wu F, Jones G, Cicuttini F, et al
    The association between incident vertebral deformities, health-related quality of life and functional impairment: a 10.7-year cohort study.
    Osteoporos Int. 2021;32:2247-2255.
    PubMed     Abstract available


    October 2021
  431. SAITO M, Moore-Lotridge SN, Uppuganti S, Egawa S, et al
    Determining the pharmacologic window of bisphosphonates that mitigates severe injury-induced osteoporosis and muscle calcification, while preserving fracture repair.
    Osteoporos Int. 2021 Oct 31. pii: 10.1007/s00198-021-06208.
    PubMed     Abstract available


  432. THARABENJASIN P, Pabalan N, Jarjanazi H, Jinawath N, et al
    Associations of osteoprotegerin (OPG) TNFRSF11B gene polymorphisms with risk of fractures in older adult populations: meta-analysis of genetic and genome-wide association studies.
    Osteoporos Int. 2021 Oct 30. pii: 10.1007/s00198-021-06161.
    PubMed     Abstract available


  433. ADAMS AL, Ryan DS, Li BH, Williams SA, et al
    Outcomes post fragility fracture among members of an integrated healthcare organization.
    Osteoporos Int. 2021 Oct 23. pii: 10.1007/s00198-021-06205.
    PubMed     Abstract available


  434. PRIOR JC, Oei EHG, Brown JP, Oei L, et al
    Where's the break? Critique of radiographic vertebral fracture diagnostic methods.
    Osteoporos Int. 2021 Oct 21. pii: 10.1007/s00198-021-06207.
    PubMed    


  435. CHEN T, Jiang R, Jiang L
    Comment on "Influence of glycemic control and hypoglycemia on the risk of fracture in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies".
    Osteoporos Int. 2021 Oct 21. pii: 10.1007/s00198-021-06217.
    PubMed    


  436. LI N, van Oostwaard M, van den Bergh JP, Hiligsmann M, et al
    Health-related quality of life of patients with a recent fracture attending a fracture liaison service: a 3-year follow-up study.
    Osteoporos Int. 2021 Oct 20. pii: 10.1007/s00198-021-06204.
    PubMed     Abstract available


  437. ASPDEN RM
    RE: Advanced 2D image processing technique to predict hip fracture risk in an older population based on single DXA scans : F. Jazinizadeh, J.D. Adachi & C.E. Quenneville. Osteoporosis International volume 31, pages 1925-1933 (2020).
    Osteoporos Int. 2021 Oct 19. pii: 10.1007/s00198-021-06096.
    PubMed    


  438. JAZINIZADEH F, Adachi J, Quenneville C
    Response to Letter from Prof Aspen, re. "Advanced 2D image processing technique to predict hip fracture risk in an older population based on single DXA scans".
    Osteoporos Int. 2021 Oct 19. pii: 10.1007/s00198-021-06192.
    PubMed    


  439. LOFFLER MT, Kallweit M, Niederreiter E, Baum T, et al
    Epidemiology and reporting of osteoporotic vertebral fractures in patients with long-term hospital records based on routine clinical CT imaging.
    Osteoporos Int. 2021 Oct 14. pii: 10.1007/s00198-021-06169.
    PubMed     Abstract available


  440. COASSY A, Svedbom A, Locrelle H, Chapurlat R, et al
    Costs of patient management over 18 months following a hip, clinical vertebral, distal forearm, or proximal humerus fragility fracture in France-results from the ICUROS study.
    Osteoporos Int. 2021 Oct 12. pii: 10.1007/s00198-021-06189.
    PubMed     Abstract available


  441. CHALITSIOS CV, Shaw DE, McKeever TM
    Risk of subtrochanteric and femoral shaft fractures due to bisphosphonate therapy in asthma: a population-based nested case-control study.
    Osteoporos Int. 2021 Oct 11. pii: 10.1007/s00198-021-06197.
    PubMed     Abstract available


  442. KUO DP, Chiu YW, Chen PT, Tsai YJ, et al
    Associations between body composition and vertebral fracture risk in postmenopausal women.
    Osteoporos Int. 2021 Oct 9. pii: 10.1007/s00198-021-06178.
    PubMed     Abstract available


  443. MUSCHITZ C, Hummer M, Grillari J, Hlava A, et al
    Epidemiology and economic burden of fragility fractures in Austria.
    Osteoporos Int. 2021 Oct 8. pii: 10.1007/s00198-021-06152.
    PubMed     Abstract available


  444. RASMUSSEN NH, Sarodnik C, Bours SPG, Schaper NC, et al
    The pattern of incident fractures according to fracture site in people with T1D.
    Osteoporos Int. 2021 Oct 7. pii: 10.1007/s00198-021-06175.
    PubMed     Abstract available


  445. LAI SW
    Risk factors for hip fracture.
    Osteoporos Int. 2021 Oct 4. pii: 10.1007/s00198-021-06188.
    PubMed    


  446. SAFIPOUR Z, van der Zanden R, van den Bergh J, Janssen P, et al
    The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis.
    Osteoporos Int. 2021 Oct 3. pii: 10.1007/s00198-021-06101.
    PubMed     Abstract available


  447. MOLLER S, Skjodt MK, Yan L, Abrahamsen B, et al
    Prediction of imminent fracture risk in Canadian women and men aged 45 years or older: external validation of the Fracture Risk Evaluation Model (FREM).
    Osteoporos Int. 2021 Oct 1. pii: 10.1007/s00198-021-06165.
    PubMed     Abstract available


    September 2021
  448. NURMI-LUTHJE I, Tiihonen R, Paattiniemi EL, Sarkkinen H, et al
    Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up.
    Osteoporos Int. 2021 Sep 30. pii: 10.1007/s00198-021-06094.
    PubMed     Abstract available


  449. LESLIE WD, Yan L, Lix LM, Morin SN, et al
    Time dependency in early major osteoporotic and hip re-fractures in women and men aged 50 years and older: a population-based observational study.
    Osteoporos Int. 2021 Sep 25. pii: 10.1007/s00198-021-06166.
    PubMed     Abstract available


  450. BEAUDART C, Hiligsmann M, Li N, Lewiecki EM, et al
    Effective communication regarding risk of fracture for individuals at risk of fragility fracture: a scoping review.
    Osteoporos Int. 2021 Sep 24. pii: 10.1007/s00198-021-06151.
    PubMed     Abstract available


  451. GASSERT FT, Kufner A, Gassert FG, Leonhardt Y, et al
    MR-based proton density fat fraction (PDFF) of the vertebral bone marrow differentiates between patients with and without osteoporotic vertebral fractures.
    Osteoporos Int. 2021 Sep 18. pii: 10.1007/s00198-021-06147.
    PubMed     Abstract available


  452. BLAKER K, Wijewardene A, White E, Stokes G, et al
    Electronic search programs are effective in identifying patients with minimal trauma fractures.
    Osteoporos Int. 2021 Sep 12. pii: 10.1007/s00198-021-06105.
    PubMed     Abstract available


  453. LIU J, Gong T, Xu X, Fox KM, et al
    Heavy clinical and economic burden of osteoporotic fracture among elderly female Medicare beneficiaries.
    Osteoporos Int. 2021 Sep 10. pii: 10.1007/s00198-021-06084.
    PubMed     Abstract available


  454. LARSSON BAM, Johansson L, Mellstrom D, Johansson H, et al
    One leg standing time predicts fracture risk in older women independent of clinical risk factors and BMD.
    Osteoporos Int. 2021 Sep 8. pii: 10.1007/s00198-021-06039.
    PubMed     Abstract available


  455. THOMASIUS F, Palacios S, Alam A, Boolell M, et al
    Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis.
    Osteoporos Int. 2021 Sep 6. pii: 10.1007/s00198-021-06108.
    PubMed     Abstract available


    August 2021
  456. HACK J, Buecking B, Strauch L, Lenz J, et al
    Self-rated health status and activities of daily living in the first 12 months after fragility fractures of the pelvis-a prospective study on 134 patients.
    Osteoporos Int. 2021 Aug 31. pii: 10.1007/s00198-021-06104.
    PubMed     Abstract available


  457. HAGINO H, Sugimoto T, Tanaka S, Sasaki K, et al
    Correction to: A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese osteoporosis intervention Trial-05.
    Osteoporos Int. 2021 Aug 27. pii: 10.1007/s00198-021-06066.
    PubMed    


  458. AXELSSON KF, Litsne H, Lorentzon M
    Fractures and fall injuries after hospitalization for seasonal influenza-a national retrospective cohort study.
    Osteoporos Int. 2021 Aug 26. pii: 10.1007/s00198-021-06068.
    PubMed     Abstract available


  459. VENDRAMI C, Marques-Vidal P, Gonzalez Rodriguez E, Hans D, et al
    Thyroid-stimulating hormone is associated with trabecular bone score and 5-year incident fracture risk in euthyroid postmenopausal women: the OsteoLaus cohort.
    Osteoporos Int. 2021 Aug 19. pii: 10.1007/s00198-021-06081.
    PubMed     Abstract available


  460. DIMAI HP, Reichardt B, Zitt E, Concin H, et al
    Thirty years of hip fracture incidence in Austria: is the worst over?
    Osteoporos Int. 2021 Aug 15. pii: 10.1007/s00198-021-06086.
    PubMed     Abstract available


  461. KHALID S, Reyes C, Ernst M, Delmestri A, et al
    One- and 2-year incidence of osteoporotic fracture: a multi-cohort observational study using routinely collected real-world data.
    Osteoporos Int. 2021 Aug 15. pii: 10.1007/s00198-021-06077.
    PubMed     Abstract available


  462. NIEVES JW, Cosman F, McMahon D, Redko M, et al
    Teriparatide and pelvic fracture healing: a phase 2 randomized controlled trial.
    Osteoporos Int. 2021 Aug 12. pii: 10.1007/s00198-021-06065.
    PubMed     Abstract available


  463. BAJPAI RC
    Letter to the Editor about the article "C-reactive protein and fracture risk: an updated systematic review and meta-analysis of cohort studies through the use of both frequentist and Bayesian approaches".
    Osteoporos Int. 2021 Aug 12. pii: 10.1007/s00198-020-05750.
    PubMed    


  464. SCHEMITSCH E, Adachi JD, Brown JP, Tarride JE, et al
    Hip fracture predicts subsequent hip fracture: a retrospective observational study to support a call to early hip fracture prevention efforts in post-fracture patients.
    Osteoporos Int. 2021 Aug 11. pii: 10.1007/s00198-021-06080.
    PubMed     Abstract available


  465. MAZZUCCHELLI R, Almodovar R, Dieguez-Costa E, Crespi Villarias N, et al
    Trends in fractures in patients with spondyloarthritis: a nationwide population-based study (TREND-EspA study).
    Osteoporos Int. 2021 Aug 2. pii: 10.1007/s00198-021-06079.
    PubMed     Abstract available


    July 2021
  466. HA J, Jeong C, Han KD, Lim Y, et al
    Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data.
    Osteoporos Int. 2021 Jul 31. pii: 10.1007/s00198-021-06032.
    PubMed     Abstract available


  467. GANDA K
    Fracture liaison services: past, present and future : Editorial relating to: The impact of Fracture Liaison Services on subsequent fractures and mortality: a systematic literature review and meta-analysis.
    Osteoporos Int. 2021 Jul 16. pii: 10.1007/s00198-021-05982.
    PubMed    


  468. BOCKER W, Doobare IU, Khachatryan A, Dornstauder E, et al
    Fractures in untreated patients with osteoporosis in Germany: an InGef healthcare insurance database analysis.
    Osteoporos Int. 2021 Jul 15. pii: 10.1007/s00198-021-06051.
    PubMed     Abstract available


  469. JIANG T, Veres K, Farkas DK, Lash TL, et al
    Correction to: Post-traumatic stress disorder and incident fractures in the Danish population.
    Osteoporos Int. 2021 Jul 15. pii: 10.1007/s00198-021-06055.
    PubMed    


  470. AMIN RM, Raad M, Rao SS, Musharbash F, et al
    Survival bias may explain the appearance of the obesity paradox in hip fracture patients.
    Osteoporos Int. 2021 Jul 10. pii: 10.1007/s00198-021-06046.
    PubMed     Abstract available


  471. HOU XL, Liu JY, Fan XH, Zhang N, et al
    Secular trends of incidence and hospitalization cost of hip fracture in Tangshan, China.
    Osteoporos Int. 2021 Jul 8. pii: 10.1007/s00198-021-06050.
    PubMed     Abstract available


  472. TALEVSKI J, Sanders KM, Watts JJ, Nicholson GC, et al
    Sex differences in recovery of quality of life 12 months post-fracture in community-dwelling older adults: analyses of the Australian arm of the International Costs and Utilities Related to Osteoporotic Fractures Study (AusICUROS).
    Osteoporos Int. 2021 Jul 8. pii: 10.1007/s00198-021-06058.
    PubMed     Abstract available


  473. LIN CC, Li CI, Liu CS, Wang MC, et al
    Lifetime risks of hip fracture in patients with type 2 diabetic: Taiwan Diabetes Study.
    Osteoporos Int. 2021 Jul 6. pii: 10.1007/s00198-021-06052.
    PubMed     Abstract available


  474. SALE JEM, Yang A, Elliot-Gibson V, Jain R, et al
    Patients 80 + have similar medication initiation rates to those aged 50-79 in Ontario FLS.
    Osteoporos Int. 2021;32:1405-1411.
    PubMed     Abstract available


    June 2021
  475. VALENTIN G, Ravn MB, Jensen EK, Friis K, et al
    Socio-economic inequalities in fragility fracture incidence: a systematic review and meta-analysis of 61 observational studies.
    Osteoporos Int. 2021 Jun 25. pii: 10.1007/s00198-021-06038.
    PubMed     Abstract available


  476. MORIN SN, Yan L, Lix LM, Leslie WD, et al
    Long-term risk of subsequent major osteoporotic fracture and hip fracture in men and women: a population-based observational study with a 25-year follow-up.
    Osteoporos Int. 2021 Jun 24. pii: 10.1007/s00198-021-06028.
    PubMed     Abstract available


  477. LIOW MHL, Ganesan G, Chen JDY, Koh JSB, et al
    Excess mortality after hip fracture: fracture or pre-fall comorbidity?
    Osteoporos Int. 2021 Jun 15. pii: 10.1007/s00198-021-06023.
    PubMed     Abstract available


  478. EVENEPOEL P, Cunningham J, Ferrari S, Haarhaus M, et al
    Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism.
    Osteoporos Int. 2021 Jun 15. pii: 10.1007/s00198-021-05975.
    PubMed     Abstract available


  479. MAGNUSDOTTIR R, Gohin S, Ter Heegde F, Hopkinson M, et al
    Fracture-induced pain-like behaviours in a femoral fracture mouse model.
    Osteoporos Int. 2021 Jun 2. pii: 10.1007/s00198-021-05991.
    PubMed     Abstract available


  480. CHOKSI IN, Cox A, Robinson C, Bale A, et al
    Novel homozygous variant in BMP1 associated with a rare osteogenesis imperfecta phenotype.
    Osteoporos Int. 2021;32:1239-1244.
    PubMed     Abstract available


  481. PEPE J, Bonnet N, Cipriani C, Ferrara C, et al
    Higher serum levels of a cathepsin K-generated periostin fragment are associated with fractures in postmenopausal women with primary hyperparathyroidism: a pilot study.
    Osteoporos Int. 2021 Jun 1. pii: 10.1007/s00198-021-06018.
    PubMed     Abstract available


    May 2021
  482. IKI M, Winzenrieth R, Tamaki J, Sato Y, et al
    Predictive ability of novel volumetric and geometric indices derived from dual-energy X-ray absorptiometric images of the proximal femur for hip fracture compared with conventional areal bone mineral density: the Japanese Population-based Osteoporosis
    Osteoporos Int. 2021 May 26. pii: 10.1007/s00198-021-06013.
    PubMed     Abstract available


  483. PAL R, Bhadada SK, Mukherjee S, Banerjee M, et al
    Fracture risk in hypoparathyroidism: a systematic review and meta-analysis.
    Osteoporos Int. 2021 May 22. pii: 10.1007/s00198-021-05966.
    PubMed     Abstract available


  484. VAN DEN BERGH JP, Szulc P, Cheung AM, Bouxsein M, et al
    The clinical application of high-resolution peripheral computed tomography (HR-pQCT) in adults: state of the art and future directions.
    Osteoporos Int. 2021 May 22. pii: 10.1007/s00198-021-05999.
    PubMed     Abstract available


  485. CHEVALLEY T, Brandi ML, Cavalier E, Harvey NC, et al
    How can the orthopedic surgeon ensure optimal vitamin D status in patients operated for an osteoporotic fracture?
    Osteoporos Int. 2021 May 20. pii: 10.1007/s00198-021-05957.
    PubMed     Abstract available


  486. SVENSSON J, Ohlsson C, Karlsson MK, Lorentzon M, et al
    Subclinical hyperthyroidism is associated with increased risk of vertebral fractures in older men.
    Osteoporos Int. 2021 May 19. pii: 10.1007/s00198-021-05964.
    PubMed     Abstract available


  487. MEYER AC, Eklund H, Hedstrom M, Modig K, et al
    The ASA score predicts infections, cardiovascular complications, and hospital readmissions after hip fracture - A nationwide cohort study.
    Osteoporos Int. 2021 May 19. pii: 10.1007/s00198-021-05956.
    PubMed     Abstract available


  488. HAGINO H, Sugimoto T, Tanaka S, Sone T, et al
    A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05.
    Osteoporos Int. 2021 May 17. pii: 10.1007/s00198-021-05996.
    PubMed     Abstract available


  489. HANUSCH B, Prediger M, Tuck SP, Walker J, et al
    Bone turnover markers as determinants of bone density and fracture in men with distal forearm fractures: the pathogenesis examined in the Mr F study.
    Osteoporos Int. 2021 May 15. pii: 10.1007/s00198-021-06001.
    PubMed     Abstract available


  490. LIETEN S, Herrtwich A, Bravenboer B, Scheerlinck T, et al
    Analysis of the effects of a delay of surgery in patients with hip fractures: outcome and causes.
    Osteoporos Int. 2021 May 14. pii: 10.1007/s00198-021-05990.
    PubMed     Abstract available


  491. POLLMANN CT, Mellingsaeter MR, Neerland BE, Straume-Naesheim T, et al
    Orthogeriatric co-management reduces incidence of delirium in hip fracture patients.
    Osteoporos Int. 2021 May 8. pii: 10.1007/s00198-021-05974.
    PubMed     Abstract available


  492. SIM DS, Tay K, Howe TS, Koh SBJ, et al
    Preoperative severe vitamin D deficiency is a significant independent risk factor for poorer functional outcome and quality of life 6 months after surgery for fragility hip fractures.
    Osteoporos Int. 2021 May 7. pii: 10.1007/s00198-021-05970.
    PubMed     Abstract available


  493. CHANG CB, Yang RS, Chang LY, Peng JK, et al
    One-year outcomes of an osteoporosis liaison services program initiated within a healthcare system.
    Osteoporos Int. 2021 May 6. pii: 10.1007/s00198-021-05859.
    PubMed     Abstract available


  494. CASELLA M, Becciolini A, Di Donato E, Basaglia M, et al
    Internal medicine inpatients' prevalence of misdiagnosed severe osteoporosis.
    Osteoporos Int. 2021 May 5. pii: 10.1007/s00198-021-05976.
    PubMed     Abstract available


    April 2021
  495. SKIBICKI HE, Ponzio DY, Brustein JA, Post ZD, et al
    A cautionary case: osteoporotic femur fracture after robotic-assisted total knee arthroplasty.
    Osteoporos Int. 2021 Apr 30. pii: 10.1007/s00198-021-05977.
    PubMed     Abstract available


  496. YAMAMOTO Y, Chiba T, Dohmae S, Higashi K, et al
    Osteoporosis medication after fracture in older adults: an administrative data analysis.
    Osteoporos Int. 2021 Apr 29. pii: 10.1007/s00198-021-05973.
    PubMed    


  497. GU KD, Ettinger B, Grimsrud CD, Lo JC, et al
    Progression of atypical femur stress fracture after discontinuation of bisphosphonate therapy.
    Osteoporos Int. 2021 Apr 29. pii: 10.1007/s00198-021-05948.
    PubMed     Abstract available


  498. MCCLOSKEY EV, Borgstrom F, Cooper C, Harvey NC, et al
    Short time horizons for fracture prediction tools: time for a rethink.
    Osteoporos Int. 2021 Apr 29. pii: 10.1007/s00198-021-05962.
    PubMed    


  499. LYLES KW, Bauer DC, Colon-Emeric CS, Pieper CF, et al
    Zoledronic acid reduces the rate of clinical fractures after surgical repair of a hip fracture regardless of the Pretreatment bone mineral density.
    Osteoporos Int. 2021 Apr 27. pii: 10.1007/s00198-021-05923.
    PubMed     Abstract available


  500. KIM JT, Cha YH, Jeong S, Yoo JI, et al
    Subtrochanteric atypical femoral fracture induced solely by glucocorticoid without bisphosphonate treatment: a case report.
    Osteoporos Int. 2021 Apr 24. pii: 10.1007/s00198-021-05971.
    PubMed     Abstract available


  501. LIU ZM, Huang Q, Li SY, Liu YP, et al
    A 1:1 matched case-control study on dietary protein intakes and hip fracture risk in Chinese elderly men and women.
    Osteoporos Int. 2021 Apr 22. pii: 10.1007/s00198-021-05960.
    PubMed     Abstract available


  502. TENG Z, Zhu Y, Teng Y, Long Q, et al
    The analysis of osteosarcopenia as a risk factor for fractures, mortality, and falls.
    Osteoporos Int. 2021 Apr 20. pii: 10.1007/s00198-021-05963.
    PubMed     Abstract available


  503. HIDAYAT K, Fang QL, Shi BM, Qin LQ, et al
    Influence of glycemic control and hypoglycemia on the risk of fracture in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2021 Apr 16. pii: 10.1007/s00198-021-05934.
    PubMed     Abstract available


  504. SI L, Eisman JA, Winzenberg T, Sanders KM, et al
    Development and validation of the risk engine for an Australian Health Economics Model of Osteoporosis.
    Osteoporos Int. 2021 Apr 15. pii: 10.1007/s00198-021-05955.
    PubMed     Abstract available


  505. ANDRICH S, Haastert B, Neuhaus E, Frommholz K, et al
    Health care utilization and excess costs after pelvic fractures among older people in Germany.
    Osteoporos Int. 2021 Apr 10. pii: 10.1007/s00198-021-05935.
    PubMed     Abstract available


  506. LI N, Hiligsmann M, Boonen A, van Oostwaard MM, et al
    The impact of fracture liaison services on subsequent fractures and mortality: a systematic literature review and meta-analysis.
    Osteoporos Int. 2021 Apr 7. pii: 10.1007/s00198-021-05911.
    PubMed     Abstract available


  507. BARAKE M, El Eid R, Ajjour S, Chakhtoura M, et al
    Osteoporotic hip and vertebral fractures in the Arab region: a systematic review.
    Osteoporos Int. 2021 Apr 7. pii: 10.1007/s00198-021-05937.
    PubMed     Abstract available


  508. DUSSAULT PM, McCarthy D, Davis SA, Thakore-James M, et al
    High prevalence of vertebral fractures in seizure patients with normal bone density receiving chronic anti-epileptic drugs.
    Osteoporos Int. 2021 Apr 6. pii: 10.1007/s00198-021-05926.
    PubMed     Abstract available


  509. PLUSKIEWICZ W, Adamczyk P, Drozdzowska B
    Height loss in postmenopausal women-do we need more for fracture risk assessment? Results from the GO Study.
    Osteoporos Int. 2021 Apr 5. pii: 10.1007/s00198-021-05941.
    PubMed     Abstract available


  510. ORMENO ILLANES JCR, Quevedo Langenegger I
    Higher latitude and lower solar radiation influence on hip fracture admissions in Chilean older population.
    Osteoporos Int. 2021 Apr 5. pii: 10.1007/s00198-021-05910.
    PubMed     Abstract available


  511. KANIS JA, Johansson H, Harvey NC, Lorentzon M, et al
    An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines : A report for the National Osteoporosis Guideline Group (NOGG).
    Osteoporos Int. 2021 Apr 4. pii: 10.1007/s00198-021-05942.
    PubMed     Abstract available


  512. TREVISAN C, Gallinari G, Carbone A, Klumpp R, et al
    Efficiently stratifying mid-term death risk in femoral fractures in the elderly: introducing the ASAgeCoGeCC Score.
    Osteoporos Int. 2021 Apr 3. pii: 10.1007/s00198-021-05932.
    PubMed     Abstract available


    March 2021
  513. SHAH A, Hawley S, Inman DS, Cooper C, et al
    Geographical variation in surgical care and mortality following hip fracture in England: a cohort study using the National Hip Fracture Database (NHFD).
    Osteoporos Int. 2021 Mar 25. pii: 10.1007/s00198-021-05922.
    PubMed     Abstract available


  514. HARVEY NC, Kanis JA, Liu E, Vandenput L, et al
    Impact of population-based or targeted BMD interventions on fracture incidence.
    Osteoporos Int. 2021 Mar 23. pii: 10.1007/s00198-021-05917.
    PubMed     Abstract available


  515. SKJODT MK, Ernst MT, Khalid S, Libanati C, et al
    The treatment gap after major osteoporotic fractures in Denmark 2005-2014: a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medications.
    Osteoporos Int. 2021 Mar 15. pii: 10.1007/s00198-021-05890.
    PubMed     Abstract available


  516. PEKONEN SR, Kopra J, Kroger H, Rikkonen T, et al
    Regional and gender-specific analyses give new perspectives for secular trend in hip fracture incidence.
    Osteoporos Int. 2021 Mar 12. pii: 10.1007/s00198-021-05906.
    PubMed     Abstract available


  517. YANG G, Lee WYW, Hung ALH, Tang MF, et al
    Association of serum 25(OH)Vit-D levels with risk of pediatric fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2021 Mar 11. pii: 10.1007/s00198-020-05814.
    PubMed     Abstract available


  518. BARTOSCH P, Malmgren L, Kristensson J, McGuigan FE, et al
    In community-dwelling women frailty is associated with imminent risk of osteoporotic fractures.
    Osteoporos Int. 2021 Mar 4. pii: 10.1007/s00198-021-05886.
    PubMed     Abstract available


  519. GONG XF, Li XP, Zhang LX, Center JR, et al
    Current status and distribution of hip fractures among older adults in China.
    Osteoporos Int. 2021 Mar 2. pii: 10.1007/s00198-021-05849.
    PubMed     Abstract available


  520. BARZILAY JI, Buzkova P, Djousse L, Ix J, et al
    Serum non-esterified fatty acid levels and hip fracture risk: The Cardiovascular Health Study.
    Osteoporos Int. 2021 Mar 2. pii: 10.1007/s00198-021-05897.
    PubMed     Abstract available


    February 2021
  521. TARRIDE JE, Adachi JD, Brown JP, Schemitsch E, et al
    Incremental costs of fragility fractures: a population-based matched -cohort study from Ontario, Canada.
    Osteoporos Int. 2021 Feb 18. pii: 10.1007/s00198-021-05877.
    PubMed     Abstract available


  522. DRIESSEN JHM, van Dort MJ, Romme EAPM, Wouters EFM, et al
    Associations between bone attenuation and prevalent vertebral fractures on chest CT scans differ with vertebral fracture locations.
    Osteoporos Int. 2021 Feb 16. pii: 10.1007/s00198-020-05719.
    PubMed     Abstract available


  523. ENGLISH S, Coyle L, Bradley S, Wilton W, et al
    Virtual fracture liaison clinics in the COVID era: an initiative to maintain fracture prevention services during the pandemic associated with positive patient experience.
    Osteoporos Int. 2021 Feb 13. pii: 10.1007/s00198-021-05882.
    PubMed     Abstract available


  524. VALDERRABANO RJ, Buzkova P, Chang PY, Zakai NA, et al
    Associations of hemoglobin and change in hemoglobin with risk of incident hip fracture in older men and women: the cardiovascular health study.
    Osteoporos Int. 2021 Feb 12. pii: 10.1007/s00198-021-05873.
    PubMed     Abstract available


  525. HSU HE, Hsu YP, Yu CH
    Multiple vertebral compression fractures in a human immunodeficiency virus-positive patient with glucocorticoid-induced Cushing syndrome treated with percutaneous vertebroplasty: a case report.
    Osteoporos Int. 2021 Feb 11. pii: 10.1007/s00198-021-05880.
    PubMed     Abstract available


  526. ERWIN J, Enki DG, Woolf AD
    Younger people with rheumatoid arthritis are at increased risk of fracture even before age 50 years: a population-based cohort study.
    Osteoporos Int. 2021 Feb 11. pii: 10.1007/s00198-021-05862.
    PubMed     Abstract available


  527. MICHALSKI AS, Besler BA, Burt LA, Boyd SK, et al
    Opportunistic CT screening predicts individuals at risk of major osteoporotic fracture.
    Osteoporos Int. 2021 Feb 10. pii: 10.1007/s00198-021-05863.
    PubMed     Abstract available


  528. CHANDRAN M, Ganesan G, Tan KB, Reginster JY, et al
    Using health-economic evidence to support policy-level decision-making in Singapore-sensitivity analysis that provides further confidence in fracture probability-based cost-effective intervention thresholds.
    Osteoporos Int. 2021 Feb 10. pii: 10.1007/s00198-021-05876.
    PubMed    


  529. EASTMAN K, Gerlach M, Piec I, Greeves J, et al
    Effectiveness of parathyroid hormone (PTH) analogues on fracture healing: a meta-analysis.
    Osteoporos Int. 2021 Feb 9. pii: 10.1007/s00198-021-05847.
    PubMed     Abstract available


  530. KANIS JA, Johansson H, Harvey NC, Gudnason V, et al
    The effect on subsequent fracture risk of age, sex, and prior fracture site by recency of prior fracture.
    Osteoporos Int. 2021 Feb 4. pii: 10.1007/s00198-020-05803.
    PubMed     Abstract available


  531. MCCLOSKEY EV, Johansson H, Harvey NC, Lorentzon M, et al
    Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk: a post hoc analysis of the first year of the frame study.
    Osteoporos Int. 2021 Feb 3. pii: 10.1007/s00198-020-05815.
    PubMed     Abstract available


  532. EJLSMARK-SVENSSON H, Rolighed L, Harslof T, Rejnmark L, et al
    Risk of fractures in primary hyperparathyroidism: a systematic review and meta-analysis.
    Osteoporos Int. 2021 Feb 1. pii: 10.1007/s00198-021-05822.
    PubMed     Abstract available


    January 2021
  533. PLUSKIEWICZ W, Wilk R, Adamczyk P, Hajzyk M, et al
    The incidence of arm, forearm, and hip osteoporotic fractures during early stage of COVID-19 pandemic.
    Osteoporos Int. 2021 Jan 30. pii: 10.1007/s00198-020-05811.
    PubMed     Abstract available


  534. PAUL J, Devarapalli V, Johnson JT, Cherian KE, et al
    Do proximal hip geometry, trabecular microarchitecture, and prevalent vertebral fractures differ in postmenopausal women with type 2 diabetes mellitus? A cross-sectional study from a teaching hospital in southern India.
    Osteoporos Int. 2021 Jan 27. pii: 10.1007/s00198-021-05855.
    PubMed     Abstract available


  535. CHANDRAN M, Mitchell PJ, Amphansap T, Bhadada SK, et al
    Development of the Asia Pacific Consortium on Osteoporosis (APCO) Framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region.
    Osteoporos Int. 2021 Jan 27. pii: 10.1007/s00198-020-05742.
    PubMed     Abstract available


  536. SAHOTA O, van Berkel D, Ong T, Drummond A, et al
    Pelvic fragility fractures-the forgotten osteoporotic fracture!
    Osteoporos Int. 2021 Jan 25. pii: 10.1007/s00198-021-05848.
    PubMed    


  537. OSAKI M, Okuda R, Saeki Y, Okano T, et al
    Efficiency of coordinator-based osteoporosis intervention in fragility fracture patients: a prospective randomized trial.
    Osteoporos Int. 2021 Jan 23. pii: 10.1007/s00198-021-05825.
    PubMed     Abstract available


  538. HOFF M, Skovlund E, Meyer HE, Langhammer A, et al
    Does treatment with bisphosphonates protect against fractures in real life? The HUNT study, Norway.
    Osteoporos Int. 2021 Jan 21. pii: 10.1007/s00198-021-05845.
    PubMed     Abstract available


  539. LEMS WF, Paccou J, Zhang J, Fuggle NR, et al
    Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services.
    Osteoporos Int. 2021 Jan 21. pii: 10.1007/s00198-020-05804.
    PubMed     Abstract available


  540. CUMMINGS SR, Eastell R
    Authors' response to KD Stathopoulos regarding "Stop (Mis)classifying Fractures as High or Low Trauma or as Fragility Fractures".
    Osteoporos Int. 2021 Jan 21. pii: 10.1007/s00198-020-05656.
    PubMed    


  541. STATHOPOULOS KD
    Are all fractures the same?
    Osteoporos Int. 2021 Jan 21. pii: 10.1007/s00198-020-05414.
    PubMed    


  542. GOU P, Wang Z, Zhao Z, Wang Y, et al
    Restoration of the intravertebral stability in Kummell's disease following the treatment of severe postmenopausal osteoporosis by 1-34PTH-a retrospective study.
    Osteoporos Int. 2021 Jan 20. pii: 10.1007/s00198-020-05761.
    PubMed     Abstract available


  543. WANDELL P, Li X, Carlsson AC, Sundquist J, et al
    Osteoporotic fractures in second-generation immigrants and Swedish natives.
    Osteoporos Int. 2021 Jan 19. pii: 10.1007/s00198-020-05776.
    PubMed     Abstract available


  544. LANE NE, Saag K, O'Neill TJ, Manion M, et al
    Correction to: Real-world bone turnover marker use: impact on treatment decisions and fracture.
    Osteoporos Int. 2021 Jan 19. pii: 10.1007/s00198-021-05828.
    PubMed    


  545. LU K, Yin Y, Li C, Jin Y, et al
    Efficacy of annual zoledronic acid in initial percutaneous kyphoplasty patients with osteoporotic vertebral compression fractures: a 3-year follow-up study.
    Osteoporos Int. 2021 Jan 18. pii: 10.1007/s00198-020-05816.
    PubMed     Abstract available


  546. POWELL J, Michael A
    Peri-operative derangement in liver function tests in older patients with neck of femur fracture.
    Osteoporos Int. 2021 Jan 18. pii: 10.1007/s00198-021-05827.
    PubMed     Abstract available


  547. GUANABENS N, Olmos JM, Hernandez JL, Cerda D, et al
    Vertebral fractures are increased in rheumatoid arthritis despite recent therapeutic advances: a case-control study.
    Osteoporos Int. 2021 Jan 18. pii: 10.1007/s00198-021-05824.
    PubMed     Abstract available


  548. LIU CS, Feasel AL, Kline GA, Billington EO, et al
    Pharmacotherapy decisions among postmenopausal women attending a group medical consultation or a one-on-one specialist consultation at an osteoporosis center: an observational cohort study.
    Osteoporos Int. 2021 Jan 18. pii: 10.1007/s00198-021-05823.
    PubMed     Abstract available


  549. SHIM BJ, Lee MH, Lim JY, Gong HS, et al
    A longitudinal histologic evaluation of vitamin D receptor expression in the skeletal muscles of patients with a distal radius fracture.
    Osteoporos Int. 2021 Jan 16. pii: 10.1007/s00198-020-05809.
    PubMed     Abstract available


  550. WU YF, Lu K, Girgis C, Preda M, et al
    Postpartum bilateral sacral stress fracture without osteoporosis-a case report and literature review.
    Osteoporos Int. 2021 Jan 13. pii: 10.1007/s00198-020-05788.
    PubMed     Abstract available


  551. BILLINGTON EO, Leslie WD, Brown JP, Prior JC, et al
    Simulated effects of early menopausal bone mineral density preservation on long-term fracture risk: a feasibility study.
    Osteoporos Int. 2021 Jan 12. pii: 10.1007/s00198-021-05826.
    PubMed     Abstract available


  552. HANS D, Shevroja E, Leslie WD
    Evolution in fracture risk assessment: artificial versus augmented intelligence.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05737.
    PubMed    


  553. YU WY, Hwang HF, Chen CY, Lin MR, et al
    Situational risk factors for fall-related vertebral fractures in older men and women.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05799.
    PubMed     Abstract available


  554. DE VRIES BCS, Hegeman JH, Nijmeijer W, Geerdink J, et al
    Comparing three machine learning approaches to design a risk assessment tool for future fractures: predicting a subsequent major osteoporotic fracture in fracture patients with osteopenia and osteoporosis.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05735.
    PubMed     Abstract available


  555. LV F, Cai X, Zhang R, Zhou L, et al
    Sex-specific associations of serum insulin-like growth factor-1 with bone density and risk of fractures in Chinese patients with type 2 diabetes.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05790.
    PubMed     Abstract available


  556. ICONARU L, Moreau M, Baleanu F, Kinnard V, et al
    Risk factors for imminent fractures: a substudy of the FRISBEE cohort.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05772.
    PubMed     Abstract available


  557. ZHANG Z, Zhou X, Shu L, Hu M, et al
    The association between overweight/obesity and vertebral fractures in older adults: a meta-analysis of observational studies.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05764.
    PubMed     Abstract available


  558. TRAN O, Silverman S, Xu X, Bonafede M, et al
    Long-term direct and indirect economic burden associated with osteoporotic fracture in US postmenopausal women.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05769.
    PubMed     Abstract available


  559. THONG EP, Milat F, Enticott JC, Joham AE, et al
    The diabetes-fracture association in women with type 1 and type 2 diabetes is partially mediated by falls: a 15-year longitudinal study.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05771.
    PubMed     Abstract available


  560. SORESKOG E, Borgstrom F, Lindberg I, Strom O, et al
    A novel economic framework to assess the cost-effectiveness of bone-forming agents in the prevention of fractures in patients with osteoporosis.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05765.
    PubMed     Abstract available


  561. SOLLING AS, Christensen DH, Darvalics B, Harslof T, et al
    Fracture rates in patients discontinuing alendronate treatment in real life: a population-based cohort study.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05745.
    PubMed     Abstract available


  562. SORESKOG E, Lindberg I, Kanis JA, Akesson KE, et al
    Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden.
    Osteoporos Int. 2021 Jan 6. pii: 10.1007/s00198-020-05780.
    PubMed     Abstract available


  563. PATEL R, Bhimjiyani A, Ben-Shlomo Y, Gregson CL, et al
    Social deprivation predicts adverse health outcomes after hospital admission with hip fracture in England.
    Osteoporos Int. 2021 Jan 5. pii: 10.1007/s00198-020-05768.
    PubMed     Abstract available



  564. Retraction Note to: Changes in Bone and Calcium Metabolism Following Hip Fracture in Elderly Patients.
    Osteoporos Int. 2021 Jan 4. pii: 10.1007/s00198-020-05777.
    PubMed    


  565. SAHOTA A, Ong T, Kumar A, Simmonds L, et al
    Vertebroplasty for vertebral fragility fractures in the 'very elderly': experience from a regional UK spine unit.
    Osteoporos Int. 2021 Jan 4. pii: 10.1007/s00198-020-05770.
    PubMed    


  566. SAPKOTA HR, Nune A, Bateman J, Venkatachalam S, et al
    A pragmatic proposal for triaging DXA testing during the COVID-19 global pandemic.
    Osteoporos Int. 2021;32:1-6.
    PubMed     Abstract available


    December 2020
  567. HOPKINS TJ, Eggington S, Quinn M, Nichols-Ricker CI, et al
    Cost-effectiveness of balloon kyphoplasty and vertebroplasty versus conservative medical management in the USA.
    Osteoporos Int. 2020;31:2461-2471.
    PubMed     Abstract available


    November 2020
  568. DAHL C, Madsen C, Omsland TK, Sogaard AJ, et al
    Contribution of elevation and residential proximity to the coast in explaining geographic variations in hip fracture incidence. A Norwegian Epidemiologic Osteoporosis Studies (NOREPOS) study.
    Osteoporos Int. 2020 Nov 27. pii: 10.1007/s00198-020-05736.
    PubMed     Abstract available


  569. BELAYA Z, Golounina O, Nikitin A, Tarbaeva N, et al
    Multiple bilateral hip fractures in a patient with dyskeratosis congenita caused by a novel mutation in the PARN gene.
    Osteoporos Int. 2020 Nov 27. pii: 10.1007/s00198-020-05758.
    PubMed     Abstract available


  570. OZAKI D, Kubota R, Maeno T, Abdelhakim M, et al
    Association between gut microbiota, bone metabolism, and fracture risk in postmenopausal Japanese women.
    Osteoporos Int. 2020 Nov 25. pii: 10.1007/s00198-020-05728.
    PubMed     Abstract available


  571. LANE NE, Saag K, O'Neill TJ, Manion M, et al
    Real-world bone turnover marker use: impact on treatment decisions and fracture.
    Osteoporos Int. 2020 Nov 24. pii: 10.1007/s00198-020-05734.
    PubMed     Abstract available


  572. YILDIZ AE, Ozbalci AB, Ergen FB, Aydingoz U, et al
    Pregnancy- and lactation-associated vertebral compression fractures: MRI prevalence and characteristics.
    Osteoporos Int. 2020 Nov 24. pii: 10.1007/s00198-020-05754.
    PubMed     Abstract available


  573. INGSTAD F, Solberg LB, Nordsletten L, Thorsby PM, et al
    Vitamin D status and complications, readmissions, and mortality after hip fracture.
    Osteoporos Int. 2020 Nov 17. pii: 10.1007/s00198-020-05739.
    PubMed     Abstract available


  574. ONG T, Copeland R, Thiam CN, Cerda Mas G, et al
    Integration of a vertebral fracture identification service into a fracture liaison service: a quality improvement project.
    Osteoporos Int. 2020 Nov 10. pii: 10.1007/s00198-020-05710.
    PubMed     Abstract available


  575. KANIS JA, Harvey NC, Lorentzon M, Liu E, et al
    Combining fracture outcomes in phase 3 trials of osteoporosis: an analysis of the effects of denosumab in postmenopausal women.
    Osteoporos Int. 2020 Nov 6. pii: 10.1007/s00198-020-05699.
    PubMed     Abstract available


  576. KANIS JA, Cooper C, Dawson-Hughes B, Harvey NC, et al
    FRAX and ethnicity.
    Osteoporos Int. 2020;31:2063-2067.
    PubMed    


  577. JADZIC J, Cvetkovic D, Milovanovic P, Tomanovic N, et al
    The micro-structural analysis of lumbar vertebrae in alcoholic liver cirrhosis.
    Osteoporos Int. 2020;31:2209-2217.
    PubMed     Abstract available


    October 2020
  578. RANGANATH LR, Khedr M, Vinjamuri S, Gallagher JA, et al
    Frequency, diagnosis, pathogenesis and management of osteoporosis in alkaptonuria: data analysis from the UK National Alkaptonuria Centre.
    Osteoporos Int. 2020 Oct 29. pii: 10.1007/s00198-020-05671.
    PubMed     Abstract available


  579. HSU Y, Hsieh TJ, Ho CH, Lin CH, et al
    Effect of compression fracture on trabecular bone score at lumbar spine.
    Osteoporos Int. 2020 Oct 26. pii: 10.1007/s00198-020-05707.
    PubMed     Abstract available


  580. RIKKONEN T, Sund R, Sirola J, Honkanen R, et al
    Obesity is associated with early hip fracture risk in postmenopausal women: a 25-year follow-up.
    Osteoporos Int. 2020 Oct 23. pii: 10.1007/s00198-020-05665.
    PubMed     Abstract available


  581. SKULADOTTIR SS, Ramel A, Hjaltadottir I, Launer LJ, et al
    Correction to: Characteristics of incidence hip fracture cases in older adults participating in the longitudinal AGES-Reykjavik study.
    Osteoporos Int. 2020 Oct 21. pii: 10.1007/s00198-020-05678.
    PubMed     Abstract available


  582. LARSSON BAM, Johansson L, Johansson H, Axelsson KF, et al
    The timed up and go test predicts fracture risk in older women independently of clinical risk factors and bone mineral density.
    Osteoporos Int. 2020 Oct 21. pii: 10.1007/s00198-020-05681.
    PubMed     Abstract available


  583. KANIS JA, Johansson H, Harvey NC, Gudnason V, et al
    The use of 2-, 5-, and 10-year probabilities to characterize fracture risk after a recent sentinel fracture.
    Osteoporos Int. 2020 Oct 20. pii: 10.1007/s00198-020-05700.
    PubMed     Abstract available


  584. ASANO Y, Tajiri K, Yagishita S, Nakanishi H, et al
    Correction to: Bilateral atypical ulnar fractures occurring after long-term treatment with bisphosphonate for 7 years and with teriparatide for 2 years: a case report.
    Osteoporos Int. 2020 Oct 20. pii: 10.1007/s00198-020-05679.
    PubMed     Abstract available


  585. MCCLOSKEY EV, Harvey NC, Johansson H, Lorentzon M, et al
    Global impact of COVID-19 on non-communicable disease management: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures.
    Osteoporos Int. 2020 Oct 14. pii: 10.1007/s00198-020-05542.
    PubMed     Abstract available


  586. LAROCHE M, Champs B, Couture G, Degboe Y, et al
    Consequence of vertebral fracture cascades: about a cohort of 79 patients.
    Osteoporos Int. 2020 Oct 14. pii: 10.1007/s00198-020-05581.
    PubMed    


  587. DOMICIANO DS, Machado LG, Figueiredo CP, Caparbo VF, et al
    Incidence and risk factors for osteoporotic non-vertebral fracture in low-income community-dwelling elderly: a population-based prospective cohort study in Brazil. The Sao Paulo Ageing and Health (SPAH) study.
    Osteoporos Int. 2020 Oct 10. pii: 10.1007/s00198-020-05669.
    PubMed     Abstract available


  588. CUNDY T
    Treat-to-target-mainstream or marketing?
    Osteoporos Int. 2020;31:1835-1836.
    PubMed    


    September 2020
  589. WALSH ME, Ferris H, Coughlan T, Hurson C, et al
    Trends in hip fracture care in the Republic of Ireland from 2013 to 2018: results from the Irish Hip Fracture Database.
    Osteoporos Int. 2020 Sep 30. pii: 10.1007/s00198-020-05636.
    PubMed     Abstract available


  590. ZHU K, Zhang J, Zhang C, Zhao Z, et al
    Therapeutic efficacy of zoledronic acid combined with calcitriol in elderly patients receiving total hip arthroplasty or hemiarthroplasty for osteoporotic femoral neck fracture.
    Osteoporos Int. 2020 Sep 28. pii: 10.1007/s00198-020-05637.
    PubMed     Abstract available


  591. LEWIECKI EM, Wright NC, Singer AJ
    Racial disparities, FRAX, and the care of patients with osteoporosis.
    Osteoporos Int. 2020 Sep 26. pii: 10.1007/s00198-020-05655.
    PubMed    


  592. CLYNES MA, Westbury LD, Dennison EM, Kanis JA, et al
    Bone densitometry worldwide: a global survey by the ISCD and IOF.
    Osteoporos Int. 2020;31:1779-1786.
    PubMed     Abstract available


  593. LIM KT, Choi WJ
    Effect of fall characteristics on the severity of hip impact during a fall on the ground from standing height.
    Osteoporos Int. 2020;31:1713-1719.
    PubMed     Abstract available


    August 2020
  594. CHANDRAN M, Ganesan G, Tan KB, Reginster JY, et al
    Cost-effectiveness of FRAX(R)-based intervention thresholds for management of osteoporosis in Singaporean women.
    Osteoporos Int. 2020 Aug 14. pii: 10.1007/s00198-020-05536.
    PubMed     Abstract available


  595. THOMAS T, Casado E, Geusens P, Lems WF, et al
    Is a treat-to-target strategy in osteoporosis applicable in clinical practice? Consensus among a panel of European experts.
    Osteoporos Int. 2020 Aug 7. pii: 10.1007/s00198-020-05569.
    PubMed     Abstract available


    July 2020
  596. YOKOMOTO-UMAKOSHI M, Umakoshi H, Ogata M, Fukumoto T, et al
    Coexistence of osteoporosis and atherosclerosis in pheochromocytoma: new insights into its long-term management.
    Osteoporos Int. 2020 Jul 2. pii: 10.1007/s00198-020-05527.
    PubMed     Abstract available


    June 2020
  597. VAN CAMP L, Dejaeger M, Tournoy J, Gielen E, et al
    Association of orthogeriatric care models with evaluation and treatment of osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2020 Jun 27. pii: 10.1007/s00198-020-05512.
    PubMed     Abstract available


  598. CHANDRAN M, Bhadada SK, Ebeling PR, Gilchrist NL, et al
    IQ driving QI: the Asia Pacific Consortium on Osteoporosis (APCO): an innovative and collaborative initiative to improve osteoporosis care in the Asia Pacific.
    Osteoporos Int. 2020 Jun 19. pii: 10.1007/s00198-020-05495.
    PubMed     Abstract available


    May 2020
  599. RAMPERSAD C, Whitlock RH, Leslie WD, Rigatto C, et al
    Trabecular bone score in patients with chronic kidney disease.
    Osteoporos Int. 2020 May 21. pii: 10.1007/s00198-020-05458.
    PubMed     Abstract available


  600. BASSATNE A, Harb H, Jaafar B, Romanos J, et al
    Disease burden of osteoporosis and other non-communicable diseases in Lebanon.
    Osteoporos Int. 2020 May 6. pii: 10.1007/s00198-020-05433.
    PubMed     Abstract available


    April 2020
  601. SCHOEB M, Malgo F, Peeters JJM, Winter EM, et al
    Treatments of osteoporosis increase bone material strength index in patients with low bone mass.
    Osteoporos Int. 2020 Apr 8. pii: 10.1007/s00198-020-05375.
    PubMed     Abstract available


    March 2020
  602. STROM O, Lauppe R, Ljunggren O, Spangeus A, et al
    Real-world effectiveness of osteoporosis treatment in the oldest old.
    Osteoporos Int. 2020 Mar 30. pii: 10.1007/s00198-020-05380.
    PubMed     Abstract available


  603. ICONARU L, Smeys C, Baleanu F, Kinnard V, et al
    Osteoporosis treatment gap in a prospective cohort of volunteer women.
    Osteoporos Int. 2020 Mar 3. pii: 10.1007/s00198-020-05339.
    PubMed     Abstract available


    February 2020
  604. ADAMI G, Saag KG, Mudano AS, Rahn EJ, et al
    Factors associated with the contemplative stage of readiness to initiate osteoporosis treatment.
    Osteoporos Int. 2020 Feb 4. pii: 10.1007/s00198-020-05312.
    PubMed     Abstract available


  605. LUO Y
    Age-related periosteal expansion at femoral neck among elderly women may maintain bending stiffness, but not femoral strength.
    Osteoporos Int. 2020;31:371-377.
    PubMed     Abstract available


    January 2020
  606. BALLESTA S, Guerri-Fernandez RC, Chillaron JJ, Guell A, et al
    The use of microindentation for the study of bone properties in type 1 diabetes mellitus patients.
    Osteoporos Int. 2020;31:175-180.
    PubMed     Abstract available


  607. YAHAYA SA, Ripin ZM, Ridzwan MIZ
    Test systems for the biomechanical evaluation of hip protectors: a systematic review.
    Osteoporos Int. 2020;31:43-58.
    PubMed     Abstract available


    December 2019
  608. HOWE JG, Hill RS, Stroncek JD, Shaul JL, et al
    Treatment of bone loss in proximal femurs of postmenopausal osteoporotic women with AGN1 local osteo-enhancement procedure (LOEP) increases hip bone mineral density and hip strength: a long-term prospective cohort study.
    Osteoporos Int. 2019 Dec 4. pii: 10.1007/s00198-019-05230.
    PubMed     Abstract available


  609. NASOMYONT N, Hornung LN, Wasserman H
    Intravenous bisphosphonate therapy in children with spinal muscular atrophy.
    Osteoporos Int. 2019 Dec 2. pii: 10.1007/s00198-019-05227.
    PubMed     Abstract available


    November 2019
  610. PALCU P, Munce S, Jaglal SB, Allin S, et al
    Understanding patient experiences and challenges to osteoporosis care delivered virtually by telemedicine: a mixed methods study.
    Osteoporos Int. 2019 Nov 23. pii: 10.1007/s00198-019-05182.
    PubMed     Abstract available


  611. CUI L, He T, Jiang Y, Li M, et al
    Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data.
    Osteoporos Int. 2019 Nov 21. pii: 10.1007/s00198-019-05173.
    PubMed     Abstract available


    October 2019
  612. PARSONS CM, Harvey N, Shepstone L, Kanis JA, et al
    Systematic screening using FRAX((R)) leads to increased use of, and adherence to, anti-osteoporosis medications: an analysis of the UK SCOOP trial.
    Osteoporos Int. 2019 Oct 12. pii: 10.1007/s00198-019-05142.
    PubMed     Abstract available


  613. CORNELISSEN D, Boonen A, Bours S, Evers S, et al
    Understanding patients' preferences for osteoporosis treatment: the impact of patients' characteristics on subgroups and latent classes.
    Osteoporos Int. 2019 Oct 12. pii: 10.1007/s00198-019-05154.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Fractures is free of charge.